10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

FORM 10-Q/A

(Amendment No. 1)

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2014

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-9819

DYNEX CAPITAL, INC.

(Exact name of registrant as specified in its charter)

Virginia	52-1549373
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia	23060-9245
(Address of principal executive offices)	(Zip Code)
(804) 217-5800 (Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes           x           No           o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes           x           No           o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes           o           No           x

On May 2, 2014, the registrant had 54,698,963 shares outstanding of common stock, $0.01 par value, which is the registrant’s only class of common stock.

Explanatory Note

This Amendment No. 1 (this “Amendment”) to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 of Dynex Capital, Inc. (the “Company”) filed on May 12, 2014 (the “Original Filing”) is being filed to correct the below-described inadvertent typographical errors in Part I, Item 3, “Quantitative and Qualitative Disclosures About Market Risk” and Exhibits 31.1, 31.2 and 32.1 of the Original Filing:

• Part I, Item 3, “Quantitative and Qualitative Disclosures About Market Risk”: The percentages in the second column of the first table under the heading “Interest Rate Risk-Effect of Changes in Interest Rates on Net Interest Income and Market Value” were erroneously given as (12.5)% instead of the correct percentage of (19.1)% for the +100 basis point shift scenario, (1.6)% instead of the correct percentage of (8.2)% for the +50 basis point shift scenario, and 8.0% instead of the correct percentage of 1.4% for the -50 basis point shift scenario;

• Exhibits 31.1 and 31.2: The first numbered paragraph in each of Exhibit 31.1 and 31.2 erroneously referred to “this Annual Report on Form 10-K” instead of referring to “this Quarterly Report on Form 10-Q;” and

• Exhibit 32.1: The exhibit erroneously referred to “the Annual Report on Form 10-K of Dynex Capital, Inc. (the “Company”) for the fiscal year ended March 31, 2014” instead of referring to “the Quarterly Report on Form 10-Q of Dynex Capital, Inc. (the “Company”) for the fiscal quarter ended March 31, 2014.”

In order to comply with requirements of the Securities and Exchange Commission applicable to the filing of this Amendment, we are including the entirety of the Quarterly Report on Form 10-Q in the Amendment. Other than as expressly set forth above, however, this Amendment does not, and does not purport to, update or change the information in any Item of the Original Filing or reflect any events that have occurred after the Original Filing was filed. The Amendment continues to speak as of the date of the Original Filing.

i

DYNEX CAPITAL, INC.

FORM 10-Q/A

INDEX

			Page
PART I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Balance Sheets as of March 31, 2014 (unaudited) and December 31, 2013	1
		Consolidated Statements of Comprehensive Income for the three months ended March 31, 2014 (unaudited) and March 31, 2013 (unaudited)	2
		Consolidated Statement of Shareholders' Equity for the three months ended March 31, 2014 (unaudited) and March 31, 2013 (unaudited)	3
		Consolidated Statements of Cash Flows for the three months ended March 31, 2014 (unaudited) and March 31, 2013 (unaudited)	4
		Notes to the Unaudited Consolidated Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	43
	Item 4.	Controls and Procedures	49
PART II.	OTHER INFORMATION
	Item 1.	Legal Proceedings	50
	Item 1A.	Risk Factors	50
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	50
	Item 3.	Defaults Upon Senior Securities	50
	Item 4.	Mine Safety Disclosures	50
	Item 5.	Other Information	50
	Item 6.	Exhibits	51
SIGNATURES			52

ii

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

CONSOLIDATED BALANCE SHEETS

(amounts in thousands except share data)

	March 31, 2014			December 31, 2013
ASSETS	(unaudited)
Mortgage-backed securities (including pledged of $3,798,331 and      $3,873,584, respectively)	$	3,959,852		$	4,018,161
Mortgage loans held for investment, net	53,804			55,423
Cash and cash equivalents	61,168			69,330
Restricted cash	18,242			13,385
Derivative assets	12,064			18,488
Principal receivable on investments	8,112			12,999
Accrued interest receivable	23,387			21,703
Other assets, net	7,653			7,648
Total assets	$	4,144,282		$	4,217,137
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities:
Repurchase agreements	$	3,485,544		$	3,580,754
Payable for unsettled mortgage-backed securities	16,086			10,358
Non-recourse collateralized financing	12,394			12,914
Derivative liabilities	11,137			6,681
Accrued interest payable	2,846			2,548
Accrued dividends payable	15,612			16,601
Other liabilities	1,648			1,405
Total liabilities	3,545,267			3,631,261
Shareholders’ equity:
Preferred stock, par value $.01 per share, 8.5% Series A Cumulative Redeemable; 8,000,000 shares authorized; 2,300,000 shares issued and outstanding ($57,500 aggregate liquidation preference)	55,407			55,407
Preferred stock, par value $.01 per share, 7.625% Series B Cumulative Redeemable; 7,000,000 shares authorized; 2,250,000 shares issued and outstanding($56,250 aggregate liquidation preference)	54,251			54,251
Common stock, par value $.01 per share, 200,000,000 shares authorized; 54,697,307 and 54,310,484 shares issued and outstanding, respectively	547			543
Additional paid-in capital	761,827			761,550
Accumulated other comprehensive loss	(4,256		)	(33,816		)
Accumulated deficit	(268,761		)	(252,059		)
Total shareholders' equity	599,015			585,876
Total liabilities and shareholders’ equity	$	4,144,282		$	4,217,137

See notes to unaudited consolidated financial statements.

1

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

(amounts in thousands except per share data)

	Three Months Ended
	March 31,
	2014			2013
Interest income:
Mortgage-backed securities	$	26,902		$	32,039
Mortgage loans held for investment	738			943
	27,640			32,982
Interest expense:
Repurchase agreements	7,611			10,218
Non-recourse collateralized financing	22			238
	7,633			10,456
Net interest income	20,007			22,526
Provision for loan losses	—			(261		)
Loss on derivative instruments, net	(13,422		)	(17		)
(Loss) gain on sale of investments, net	(3,307		)	1,391
Fair value adjustments, net	32			(140		)
Other income (expense), net	75			(88		)
General and administrative expenses:
Compensation and benefits	(2,552		)	(2,358		)
Other general and administrative	(1,567		)	(1,450		)
Net (loss) income	(734		)	19,603
Preferred stock dividends	(2,294		)	(1,222		)
Net (loss) income to common shareholders	$	(3,028	)	$	18,381
Other comprehensive income:
Change in fair value of available-for-sale investments	23,965			5,897
Reclassification adjustment for (loss) gain on sale of investments, net	3,307			(1,391		)
Change in fair value of cash flow hedges	—			437
Reclassification adjustment for cash flow hedges (including de-designated hedges)	2,288			4,103
Total other comprehensive income	29,560			9,046
Comprehensive income to common shareholders	$	26,532		$	27,427
Weighted average common shares - basic and diluted	54,626			54,300
Net (loss) income per common share - basic and diluted	$	(0.06	)	$	0.34

See notes to unaudited consolidated financial statements.

2

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)

(amounts in thousands)

	Preferred Stock		Common Stock			Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Accumulated Deficit			Total
Balance as of  December 31, 2013	$	109,658	$	543		$	761,550		$	(33,816	)	$	(252,059	)	$	585,876
Stock issuance	—		1			143			—			—			144
Granting and vesting of restricted stock	—		4			668			—			—			672
Amortization of stock issuance costs	—		—			(30		)	—			—			(30		)
Adjustments for tax withholding on share-based compensation	—		(1		)	(504		)	—			—			(505		)
Net loss	—		—			—			—			(734		)	(734		)
Dividends on preferred stock	—		—			—			—			(2,294		)	(2,294		)
Dividends on common stock	—		—			—			—			(13,674		)	(13,674		)
Other comprehensive income	—		—			—			29,560			—			29,560
Balance as of March 31, 2014	$	109,658	$	547		$	761,827		$	(4,256	)	$	(268,761	)	$	599,015

	Preferred Stock		Common Stock			Additional Paid-in Capital			Accumulated Other Comprehensive Income		Accumulated Deficit			Total
Balance as of  December 31, 2012	$	55,407	$	543		$	759,214		$	52,511	$	(250,965	)	$	616,710
Stock issuance	—		5			5,178			—		—			5,183
Granting and vesting of restricted stock	—		1			455			—		—			456
Amortization of stock issuance costs	—		—			(30		)	—		—			(30		)
Adjustments for tax withholding on share-based compensation	—		(1		)	(545		)	—		—			(546		)
Net income	—		—			—			—		19,603			19,603
Dividends on preferred stock	—		—			—			—		(1,222		)	(1,222		)
Dividends on common stock	—		—			—			—		(15,902		)	(15,902		)
Other comprehensive income	—		—			—			9,046		—			9,046
Balance as of March 31, 2013	$	55,407	$	548		$	764,272		$	61,557	$	(248,486	)	$	633,298

See notes to the unaudited consolidated financial statements.

3

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(amounts in thousands)

	Three Months Ended
	March 31,
	2014			2013
Operating activities:
Net (loss) income	$	(734	)	$	19,603
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Increase in accrued interest receivable	(1,684		)	(1,401		)
Increase (decrease) in accrued interest payable	298			(22		)
Provision for loan losses	—			261
Loss on derivative instruments, net	13,422			17
Loss (gain) on sale of investments, net	3,307			(1,391		)
Fair value adjustments, net	(32		)	140
Amortization and depreciation	34,829			32,117
Stock-based compensation expense	672			481
Other operating activities	(175		)	(4,400		)
Net cash and cash equivalents provided by operating activities	49,903			45,405
Investing activities:
Purchase of investments	(127,552		)	(438,376		)
Principal payments received on investments	128,676			215,751
Proceeds from sales of investments	59,799			31,158
Principal payments received on mortgage loans held for investment, net	1,605			5,737
Net payments on derivatives not designated as hedges	(2,542		)	(174		)
Other investing activities	(5		)	(827		)
Net cash and cash equivalents provided by (used in) investing activities	59,981			(186,731		)
Financing activities:
(Repayments of) borrowings under repurchase agreements, net	(95,314		)	144,023
Principal payments on non-recourse collateralized financing	(527		)	(2,024		)
Increase in restricted cash	(4,857		)	—
Proceeds from issuance of common stock, net of issuance costs	114			5,152
Payments related to tax withholding for share-based compensation	(505		)	(545		)
Dividends paid	(16,957		)	(16,960		)
Net cash and cash equivalents (used in) provided by financing activities	(118,046		)	129,646
Net decrease in cash and cash equivalents	(8,162		)	(11,680		)
Cash and cash equivalents at beginning of period	69,330			55,809
Cash and cash equivalents at end of period	$	61,168		$	44,129
Supplemental Disclosure of Cash Activity:
Cash paid for interest	$	4,935		$	10,381

See notes to unaudited consolidated financial statements.

4

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share and per share data)

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation

The accompanying consolidated financial statements of Dynex Capital, Inc. and its qualified real estate investment trust (“REIT”) subsidiaries and its taxable REIT subsidiary (together, “Dynex” or the “Company”) have been prepared in accordance with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. The financial information included herein is unaudited; however, in the opinion of management, all significant adjustments, consisting of normal recurring accruals considered necessary for a fair presentation of the consolidated financial statements, have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statement of income for the three months ended March 31, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statement of comprehensive income for the three months ended March 31, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation

The consolidated financial statements include the accounts of the Company, its qualified REIT subsidiaries and its taxable REIT subsidiary. The consolidated financial statements represent the Company’s accounts after the elimination of intercompany balances and transactions. The Company consolidates entities in which it owns more than 50% of the voting equity and control does not rest with others and variable interest entities in which it is determined to be the primary beneficiary in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 810-10. The Company follows the equity method of accounting for investments in which it owns greater than a 20% and less than 50% interest in partnerships and corporate joint ventures or when it is able to influence the financial and operating policies of the investee but owns less than 50% of the voting equity. The Company did not have any investments in which it owned less than a 50% interest in the voting equity as of March 31, 2014 or December 31, 2013.

In accordance with ASC Topic 810-10, the Company also consolidates certain trusts through which it has securitized mortgage loans held for investment. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

5

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period.  Actual results could differ from those estimates.  The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, allowance for loan losses, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

Federal Income Taxes

The Company believes it has complied with the requirements for qualification as a REIT under the Internal Revenue Code of 1986, as amended (the "Code").  As such, the Company believes that it qualifies as a REIT for federal income tax purposes, and it generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.  The Company uses the calendar year for both tax and financial reporting purposes.  There may be differences between taxable income and income computed in accordance with GAAP.

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated the majority of its investments in MBS as available-for-sale ("AFS"), and the remainder is designated as trading. All of the Company’s MBS are recorded at their fair value on its consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until the security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may, from time to time, sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method. Changes in the fair value of MBS designated as trading are recognized in net income within "fair value adjustments, net". Gains and losses realized upon the sale, impairment, or other disposal of a trading security are also recognized within "fair value adjustments, net".

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated AA and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual prepayment activity as well as changes in projected future cash flows in accordance with ASC Topic 310-20. The Company's projections of future cash flows are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company has purchased non-Agency MBS rated less than 'AA' by at least one national rating agency at discounts to their par value, and management does not believe these discounts to be substantial. The Company records the discount accretion into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

The accrual of interest on MBS is discontinued when, in the opinion of management, it is probable that all amounts contractually due will not be collected, and in certain instances, as a result of an other-than-temporary impairment analysis (see discussion below). All interest accrued but not collected for investments that are placed on a non-accrual status or are charged-off is reversed against interest income. Interest on these investments is accounted for on the cash-basis or cost-recovery method until

6

the affected investment or investments qualify for return to accrual status. Investments are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured.

Determination of MBS Fair Value.In accordance with ASC Topic 820, the Company determines the fair value for the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. The Company's application of ASC Topic 820 guidance is discussed further in Note 7.

Other-than-Temporary Impairment.The Company evaluates all MBS in its investment portfolio for other-than-temporary impairments ("OTTI") by comparing the amortized cost of each security in an unrealized loss position against the present value of expected future cash flows of the security. If there has been a significant adverse change in the cash flow expectations for a security resulting in its amortized cost becoming greater than the present value of its expected future cash flows, an other-than-temporary credit impairment has occurred. If the Company does not intend to sell and is not more likely than not required to sell the security, the credit loss is recognized in earnings and the balance of the unrealized loss is recognized in other comprehensive income (loss). If the Company intends to sell the security or will be more likely than not required to sell the security, the full unrealized loss is recognized in earnings.

In periods after the recognition of an OTTI loss for MBS, the Company accounts for the other-than-temporarily impaired MBS as if the debt security had been purchased on the measurement date of the OTTI at an amortized cost basis equal to the previous amortized cost basis less the OTTI recognized in earnings. For MBS for which OTTIs were recognized in earnings, the difference between the new amortized cost basis and the cash flows expected to be collected shall be accreted into interest income using the effective interest method. The Company continues to estimate the present value of cash flows expected to be collected over the life of the MBS. If upon subsequent evaluation, there is an increase in the cash flows expected to be collected or if actual cash flows are greater than cash flows previously expected, such changes will be accounted for as a prospective adjustment to the accretable yield in accordance with ASC Topic 310-30 even if the MBS would not otherwise be within the scope of that guidance. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment consist primarily of securitized mortgage loans reported at amortized cost in accordance with ASC Topic 310-10. Securitized mortgage loans are pledged to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as a portion of "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. Less than 2% of the Company's mortgage loans held for investment are unsecuritized; these loans are also reported at amortized cost. In accordance with ASC Topic 310-10, an allowance has been established for currently existing and probable losses on all of the Company's mortgage loans held for investment.

Repurchase Agreements

Repurchase agreements are treated as financings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

7

Derivative Instruments

The Company accounts for its derivative instruments in accordance with ASC Topic 815. ASC Topic 815 requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "loss on derivative instruments, net".

The Company has Eurodollar futures, which are valued based on closing exchange prices. Variation margin is exchanged daily to settle any changes in the value of the Eurodollar futures. Gains and losses associated with purchases and short sales of futures contracts are reported in "loss on derivative instruments, net" on our consolidated statement of comprehensive income.

The Company has elected to use the portfolio exception in ASC 820-10-35-18D with respect to measuring counterparty credit risk for derivative instruments. The Company manages credit risk for its derivative positions on a counterparty-by-counterparty basis (that is, on the basis of its net portfolio exposure with each counterparty), consistent with its risk management strategy for such transactions. The Company manages credit risk by considering indicators of risk such as credit ratings, and by negotiating terms in its ISDA master netting arrangements and, if applicable, any associated Credit Support Annex documentation, with each individual counterparty. Since the effective date of ASC 820, management has monitored and measured credit risk and calculated credit valuation adjustments for its derivative transactions on the basis of its relationships at the counterparty portfolio level. Management receives reports from an independent third-party valuation specialist on a monthly basis providing the credit valuation adjustments at the counterparty portfolio level for purposes of reviewing and managing its credit risk exposures. Since the portfolio exception applies only to the fair value measurement and not to financial statement presentation, the portfolio-level adjustments are then allocated in a reasonable and consistent manner each period to the individual assets or liabilities that make up the group, in accordance with other applicable accounting guidance and the Company's accounting policy elections.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Stock-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant stock-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights (“SARs”), dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date as required by ASC Topic 718. The Company does not currently have any other stock-based compensation issued or outstanding other than restricted stock. Please see Note 8 for additional disclosures regarding the Company's SIP.

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, we evaluate whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or

8

range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed. Please refer to Note 9 for information on the Company's contingencies.

Recent Accounting Pronouncements

There are no recently issued accounting pronouncements which have had or are expected to have a material impact on the Company's consolidated financial statements.

NOTE 2 – NET (LOSS) INCOME PER COMMON SHARE

Net (loss) income per common share is presented on both a basic and diluted basis.  Because the Company's Series A Cumulative Redeemable Preferred Stock and Series B Cumulative Redeemable Preferred Stock are redeemable at the Company's option for cash only, and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares is excluded from the calculation of diluted net (loss) income per common share. For the three months ended March 31, 2013, diluted net income per common share assumes the exercise of stock options outstanding during the period using the treasury stock method. The Company did not have any stock options outstanding for the three months ended March 31, 2014. Holders of unvested shares of our issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC 260-10 and therefore are included in the computation of basic net (loss) income per share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted is converted to one equal share of common stock.

The following table presents the calculation of the numerator and denominator for both basic and diluted net (loss) income per common share for the periods indicated:

	For the Three Months Ended
	March 31, 2014						March 31, 2013
	Net  Income			Weighted-Average Common Shares			Net  Income			Weighted- Average Common Shares
Net (loss) income	$	(734	)				$	19,603
Preferred stock dividends	(2,294		)				(1,222		)
Net (loss) income to common shareholders	(3,028		)	54,625,601			18,381			54,300,020
Effect of dilutive stock options	—			—			—			754
Diluted net (loss) income to common shareholders	$	(3,028	)	54,625,601			$	18,381		54,300,774
Net (loss) income per common share:
Basic				$	(0.06	)				$	0.34
Diluted (1)				$	(0.06	)				$	0.34

(1) The Company did not have any anti-dilutive securities outstanding during the three months ended March 31, 2014 or March 31, 2013.

NOTE 3 – MORTGAGE-BACKED SECURITIES

The following table presents the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of March 31, 2014 and December 31, 2013:

9

	March 31, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,438,133	$	139,899		$	2,578,032	$	6,708	$	(45,438	)	$	2,539,302	3.20	%
CMBS	286,931		19,838			306,769		11,384		(509		)	317,644		5.23	%
CMBS IO (1)	—		461,523			461,523		11,581		(1,859		)	471,245		0.94	%
Total Agency AFS:	2,725,064		621,260			3,346,324		29,673		(47,806		)	3,328,191
Non-Agency:
RMBS	15,454		(7		)	15,447		209		(86		)	15,570		4.42	%
CMBS	375,209		(17,819		)	357,390		19,448		(842		)	375,996		5.05	%
CMBS IO (1)	—		209,301			209,301		3,374		(1,148		)	211,527		0.80	%
Total non-Agency AFS:	390,663		191,475			582,138		23,031		(2,076		)	603,093
Total AFS securities	$	3,115,727	$	812,735		$	3,928,462	$	52,704	$	(49,882	)	$	3,931,284

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $10,582,484 and $5,053,884, respectively, as of March 31, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (1)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (1)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

The Company has investments in additional Agency CMBS not included in the tables above that are designated as trading securities by the Company with fair values of $28,568 and $28,717 as of March 31, 2014 and December 31, 2013, respectively. Changes in the fair value of these Agency CMBS are recognized each reporting period within "fair value adjustments, net" as a component of the Company's net income. As of March 31, 2014 and December 31, 2013, the amortized cost of these Agency CMBS designated as trading securities was $26,786 and $26,920, respectively. The Company recognized a net unrealized loss for the three months ended March 31, 2014 of $(17) compared to a net unrealized loss of $(107) for the three months ended March 31, 2013, respectively, related to changes in fair value of these Agency CMBS designated as trading securities.

10

The following table presents certain information for those Agency MBS in an unrealized loss position as of March 31, 2014 and December 31, 2013:

	March 31, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	1,563,078	$	(29,207	)	120	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	126,578		(1,990		)	23	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	767,744	$	(18,600	)	80	$	670,402	$	(20,433	)	67
Non-Agency MBS	1,676		(86		)	5	6,310		(155		)	6

Because the principal and interest related to Agency MBS are guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac who have the implicit guarantee of the U.S. government, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s current leverage and anticipated liquidity.  Based on this analysis, the Company has determined that the unrealized losses on its Agency MBS as of March 31, 2014 and December 31, 2013 were temporary.

The Company also reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of these non-Agency MBS and the seasoning of the mortgage loans collateralizing these securities as well as the estimated future cash flows which include projected losses. The Company performed this evaluation for the non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of March 31, 2014 or December 31, 2013.

NOTE 4 – REPURCHASE AGREEMENTS

The following tables present the components of the Company’s repurchase agreements as of March 31, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	March 31, 2014
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,350,781		0.39	%	2,421,202
Agency CMBS	265,475			0.37	%	330,182
Agency CMBS IOs	382,327			1.14	%	471,173
Non-Agency RMBS	11,905			1.77	%	14,691
Non-Agency CMBS	309,398			1.22	%	371,273
Non-Agency CMBS IO	149,105			1.23	%	187,227
Securitization financing bonds	16,692			1.52	%	18,607
Deferred costs	(139		)	n/a		n/a
	$	3,485,544		0.59	%	$	3,814,355

11

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

The combined weighted average original term to maturity for the Company’s repurchase agreements decreased to 93 days as of March 31, 2014 from 114 days as of December 31, 2013. The following table provides a summary of the original maturities as of March 31, 2014 and December 31, 2013:

Original Maturity	March 31, 2014		December 31, 2013
30 days or less	$	369,542	$	206,112
31 to 60 days	715,516		492,145
61 to 90 days	987,579		665,020
91 to 120 days	545,628		783,371
121 to 190 days	867,418		1,434,349
	$	3,485,683	$	3,580,997

As of March 31, 2014, the Company had approximately $97,517 of its shareholders' equity at risk (defined as the excess of collateral pledged over the borrowing outstanding) with Wells Fargo Bank National Association together with its affiliate Wells Fargo Securities, LLC. The borrowings outstanding with that counterparty and its affiliates as of March 31, 2014 were $348,399 with a weighted average borrowing rate of 1.27%. Of the amount outstanding with this counterparty and its affiliate, $165,693 is under a two-year repurchase facility with Wells Fargo Bank National Association. The facility provides an aggregate maximum borrowing capacity of $250,000 and matures on August 6, 2015, subject to early termination provisions contained in the master repurchase agreement. The facility is collateralized primarily by CMBS IO, and its weighted average borrowing rate as of March 31, 2014 was 1.42%. Shareholders' equity at risk did not exceed 10% for any of the Company's other counterparties.

As of March 31, 2014, the Company had repurchase agreement amounts outstanding with 21 of its 31 available counterparties. The Company's counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company's REIT status.  In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in compliance with all covenants as of March 31, 2014.

12

NOTE 5 – DERIVATIVES

     The Company utilizes a variety of derivative instruments to economically hedge a portion of its exposure to market risks, primarily interest rate risk. The principal instruments used to hedge these risks are interest rate swaps and Eurodollar futures. The objective of the Company's risk management strategy is to protect the Company's earnings from rising interest rates and to mitigate declines in book value resulting from fluctuations in the fair value of the Company's assets from changing interest rates. The Company seeks to limit its exposure to changes in interest rates but does not seek to eliminate this risk. Please refer to Note 1 for information related to the Company's accounting policy for its derivative instruments.

The table below summarizes information about the Company’s derivative instruments on its consolidated balance sheet as of the dates indicated:  

			March 31, 2014					December 31, 2013
Type of Derivative Instrument	Accounting Designation	Balance Sheet Location:	Fair Value			Aggregate Notional Amount		Fair Value			Aggregate Notional Amount
Interest rate swaps	Non-hedging	Derivative assets	$	12,064		$	525,000	$	18,488		$	575,000
Interest rate swaps	Non-hedging		$	(1,378	)	$	325,000	$	(1,336	)	$	215,000
Eurodollar futures	Non-hedging		(9,759		)	9,000,000		(5,345		)	9,000,000
		Derivative liabilities	$	(11,137	)	$	9,325,000	$	(6,681	)	$	9,215,000

The following table summarizes activity related to derivative instruments for the periods indicated:

(amounts in thousands)	Interest Rate Swaps			Eurodollar Futures
Notional amount as of December 31, 2013	$	790,000		$	9,000,000
Additions	75,000			—
Settlements, terminations, or expirations	(15,000		)	—
Notional amount as of March 31, 2014(1)	$	850,000		$	9,000,000

(1) The Eurodollar futures notional amount as of March 31, 2014 represents the total notional of the 3-month contracts with expiration dates from 2016 to 2020. The maximum notional outstanding for any future 3-month period does not exceed $1,175,000.

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of March 31, 2014:

Remaining Maturity	Notional Amount		Weighted-Average Fixed Rate Swapped
37-48 months	185,000		0.92	%
49-60 months	350,000		1.62	%
61-72 months	35,000		1.24	%
73-84 months	100,000		2.08	%
85-108 months	—		—	%
109-127 months	180,000		2.13	%
	$	850,000	1.61	%

The tables below summarize the effect of the Company's interest rate derivatives reported in "loss on derivative instruments, net" within the Company's net income for the periods indicated:

13

	Three Months Ended
	March 31,
Type of Derivative Instrument	2014			2013
Interest rate swaps	$	(9,008	)	$	(17	)
Eurodollar futures	(4,414		)	—
Loss on derivative instruments, net	$	(13,422	)	$	(17	)

Effective June 30, 2013, the Company de-designated certain interest rate swap agreements as cash flow hedges under ASC Topic 815. The net unrealized loss in AOCI of $7,077 remaining on the Company's consolidated balance sheet as of March 31, 2014 is related to these interest rate swap agreements. The amount remaining in AOCI will be recognized in the Company's net income as a portion of "interest expense" over the remaining contractual life of the agreements. All forecasted transactions associated with interest rate swap agreements previously designated as cash flow hedges are expected to occur. No amounts have been reclassified to net income in any period in connection with forecasted transactions that are no longer considered probable of occurring. The Company estimates the portion of existing net unrealized loss on discontinued cash flow hedges expected to be reclassified to net income within the next 12 months is $5,525. The Company reclassified $2,288 from AOCI to net income for the three months ended March 31, 2014 related to amortization of the net unrealized loss remaining in AOCI at the time the Company discontinued its cash flow hedge accounting. For the three months ended March 31, 2013, the Company reclassified $4,103 from AOCI to net income related to recognition of interest expense from cash flow hedging transactions.

Many of the Company's interest rate swaps were entered into under bilateral agreements which contain various covenants related to the Company’s credit risk. Specifically, if the Company defaults on any of its indebtedness, including those circumstances whereby repayment of the indebtedness has not yet been accelerated by the lender, or is declared in default of any of its covenants with any counterparty, then the Company could also be declared in default under the bilateral agreement. Additionally, these agreements allow those counterparties to require settlement of its outstanding derivative transactions if the Company fails to earn GAAP net income excluding derivative gains and losses greater than one dollar as measured on a rolling two quarter basis. These interest rate agreements also contain provisions whereby, if the Company fails to maintain a minimum net amount of shareholders’ equity, then the Company may be declared in default on its derivative obligations. The Company was in compliance with all covenants under bilateral agreements on March 31, 2014.

NOTE 6 – OFFSETTING ASSETS AND LIABILITIES

The Company's derivatives and repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its assets and liabilities subject to these arrangements on a gross basis. The following tables present information regarding those assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2014 and December 31, 2013:

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Received as Collateral			Cash Received as Collateral
March 31, 2014
Derivative assets	$	12,064	$	—	$	12,064	$	(395	)	$	(7,954	)	$	3,715
December 31, 2013:
Derivative assets	$	18,488	$	—	$	18,488	$	(193	)	$	(12,141	)	$	6,154

14

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
March 31, 2014
Derivative liabilities	$	11,137	$	—	$	11,137	$	(1,340	)	$	(9,797	)	$	—
Repurchase agreements	3,485,544		—		3,485,544		(3,485,544		)	—			—
	$	3,496,681	$	—	$	3,496,681	$	(3,486,884	)	$	(9,797	)	$	—
December 31, 2013:
Derivative liabilities	$	6,681	$	—	$	6,681	$	(1,299	)	$	(5,382	)	$	—
Repurchase agreements	3,580,754		—		3,580,754		(3,580,754		)	—			—
	$	3,587,435	$	—	$	3,587,435	$	(3,582,053	)	$	(5,382	)	$	—

(1) Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.

NOTE 7 – FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity's own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. The fair value measurement of the Company's Eurodollar futures contracts are included in this category.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  The Company’s assets and liabilities measured at fair value that are generally included in this category are Agency MBS, certain non-Agency MBS, and interest rate swaps.

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date.  Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  The Company’s assets and liabilities measured at fair value that are generally included in this category are certain non-Agency MBS.

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

15

	March 31, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,959,852	$	—	$	3,893,465	$	66,387
Derivative assets	12,064		—		12,064		—
Total assets carried at fair value	$	3,971,916	$	—	$	3,905,529	$	66,387
Liabilities:
Derivative liabilities	$	11,137	$	9,759	$	1,378	$	—
Total liabilities carried at fair value	$	11,137	$	9,759	$	1,378	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

The Company did not have assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 or December 31, 2013.

The Company’s valuation of its interest rate swaps is determined using the income approach. Derivative assets and liabilities include interest rate swaps and Eurodollar futures. The primary input into the valuation of interest rate swaps is the forward interest rate swap curve, which is considered an observable input and thus their fair values are considered Level 2 measurements. The Company's valuation of its Eurodollar futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1.

The Company’s Agency MBS, as well a majority of its non-Agency MBS, are substantially similar to securities that either are currently actively traded or have been recently traded in their respective market. Their fair values are derived from an average of multiple dealer quotes and thus are considered Level 2 fair value measurements. The Company’s remaining non-Agency MBS are comprised of securities for which there are not substantially similar securities that trade frequently, and their fair values are therefore considered Level 3 measurements. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using assumptions that are confirmed to the extent possible by third party dealers or other pricing indicators. Significant inputs into those pricing models are Level 3 in nature due to the lack of readily available market quotes. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation would

16

result in a significantly different fair value measurement. Generally Level 3 assets are most sensitive to the default rate and severity assumptions.

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of March 31, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.5	%	35.0	%	8.8	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.8	%

(1) Data presented are weighted averages.

The following table presents the activity of the instruments fair valued at Level 3 during the three months ended March 31, 2014:

	Three Months
	March 31, 2014
	Level 3 Fair Values
	Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of December 31, 2013	$	70,733		$	2,747		$	73,480
Change in fair value included in OCI	27			(126		)	(99		)
Principal payments	(6,993		)	(395		)	(7,388		)
Accretion	65			329			394
Balance as of March 31, 2014	$	63,832		$	2,555		$	66,387

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,959,852	$	3,959,852	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	53,804		45,188		55,423		46,383
Derivative assets	12,064		12,064		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,485,544	$	3,485,683	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	12,394		11,915		12,914		12,414
Derivative liabilities	11,137		11,137		6,681		6,681

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate fair value of the Company's Level 3 non-Agency MBS.

(2) The difference between the recorded basis of repurchase agreements and their fair value is the deferred cost of the 2-year repurchase facility.

17

NOTE 8 – SHAREHOLDERS' EQUITY

Preferred Stock

The Company has 2,300,000 shares of its 8.50% Series A Cumulative Redeemable Preferred Stock and 2,250,000 shares of its 7.625% Series B Cumulative Redeemable Preferred Stock issued and outstanding as of March 31, 2014 (collectively, the "Preferred Stock"). The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. Except under certain limited circumstances intended to preserve the Company's REIT status, upon the occurrence of a change in control as defined in Article IIIA, Section 7(d) of the Company’s Articles of Incorporation, or to avoid the direct or indirect imposition of a penalty tax in respect of, or to protect the tax status of, any of the Company’s real estate mortgage investment conduits (“REMIC”) interests or a REMIC in which the Company may acquire an interest (as permitted by the Company’s Articles of Incorporation), the Company may not redeem the Series A Preferred Stock prior to July 31, 2017 or the Series B Preferred Stock prior to April 30, 2018. On or after these dates, at any time and from time to time, the Preferred Stock may be redeemed in whole, or in part, at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company's consolidated balance sheet.

Common Stock

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

	Three Months Ended
	March 31,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	3,938		298,304
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	442,035		139,600
Common stock forfeited for tax withholding on share-based compensation	(59,150	)	(52,385	)
Balance as of end of period	54,697,307		54,835,420

The Company had approximately 7,416,520 shares of common stock that remain available to offer and sell through its sales agent, JMP Securities LLC, under its "at the market", or "ATM" program, as of March 31, 2014.

The Company's Dividend Reinvestment and Share Purchase Plan ("DRIP") allows registered shareholders to automatically reinvest some or all of their quarterly common stock dividends in shares of the Company’s common stock and provides an opportunity for investors to purchase shares of the Company’s common stock, potentially at a discount to the prevailing market price. Of the 3,000,000 shares reserved for issuance under the Company's DRIP, there were 2,462,960 shares remaining for issuance as of March 31, 2014. The Company declared a first quarter common stock dividend of $0.25 per share payable on April 30, 2014 to shareholders of record as of April 4, 2014. There was no discount for shares purchased through the DRIP during the first quarter of 2014.

Of the $50,000 authorized by the Company's Board of Directors for the repurchase of its common stock through December 31, 2014, approximately $42,145 remains available for repurchase at the Company's option as of March 31, 2014.

2009 Stock and Incentive Plan. Of the 2,500,000 shares of common stock authorized for issuance under its 2009 Stock and Incentive Plan, the Company had 1,108,083 available for issuance as of March 31, 2014. Total stock-based compensation

18

expense recognized by the Company for the three months ended March 31, 2014 was $672 compared to $489 for the three months ended March 31, 2013.

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2014		2013
Restricted stock outstanding as of beginning of period	520,969		448,283
Restricted stock granted	428,363		139,600
Restricted stock vested	(188,620	)	(153,720	)
Restricted stock outstanding as of end of period	760,712		434,163

 The restricted stock granted during the three months ended March 31, 2014 and March 31, 2013 had combined fair values of $3,453 and $1,491, respectively, at their grant dates. As of March 31, 2014, the balance of the Company’s outstanding restricted stock remaining to be amortized into compensation expense is $6,092 of which $1,902 is expected to be amortized in the remaining nine months of 2014, $2,161 in 2015, $1,452 in 2016, $541 in 2017, and $36 in 2018. The Company did not have any other type of stock-based compensation issued or outstanding as of March 31, 2014 or December 31, 2013 other than its restricted stock.

NOTE 9 – COMMITMENTS AND CONTINGENCIES

The Company and its subsidiaries are parties to various legal proceedings. Although the ultimate outcome of those legal proceedings cannot be ascertained at this time, and the results of legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of these proceedings will not have a material effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of those proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved. Please refer to Note 1 for information on the Company's accounting policy with respect to accrual for loss contingencies. There have been no material changes during the three months ended March 31, 2014 for the legal proceedings discussed in our Annual Report on Form 10-K for the year ended December 31, 2013.

NOTE 10 – SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

19

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our unaudited financial statements and the accompanying notes included in Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2013. References herein to “Dynex,” the “Company,” “we,” “us,” and “our” include Dynex Capital, Inc. and its consolidated subsidiaries, unless the context otherwise requires. In addition to current and historical information, the following discussion and analysis contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to our future business, financial condition or results of operations. For a description of certain factors that may have a significant impact on our future business, financial condition or results of operations, see “Forward-Looking Statements” at the end of this discussion and analysis.

EXECUTIVE OVERVIEW

Company Overview

We are an internally managed mortgage real estate investment trust, or mortgage REIT, which invests in mortgage assets on a leveraged basis. Our common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "DX". We also have two series of Preferred Stock outstanding, our 8.50% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") which is traded on the NYSE under the symbol "DXPRA", and our 7.625% Series B Cumulative Redeemable Preferred Stock (the "Series B Preferred Stock") which is traded on the NYSE under the symbol "DXPRB". Our objective is to provide attractive risk-adjusted returns to our shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. We seek to provide returns to our shareholders through regular quarterly dividends and through capital appreciation.

We were formed in 1987 and commenced operations in 1988. Beginning with our inception through 2000, our operations largely consisted of originating and securitizing various types of loans, principally single-family and commercial mortgage loans and manufactured housing loans. Since 2000, we have been investing in Agency and non-Agency mortgage-backed securities (“MBS”), and we are no longer originating or securitizing mortgage loans. MBS consist of residential MBS (“RMBS”) and commercial MBS (“CMBS”), including CMBS interest-only ("IO") securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity ("GSE") such as Fannie Mae and Freddie Mac. Non-Agency MBS have no such guaranty of payment.

Our primary source of income is net interest income, which is the excess of the interest income earned on our investments over the cost of financing these investments. We invest our capital pursuant to our Operating Policies as approved by our Board of Directors which include an Investment Policy and Investment Risk Policy as discussed in Part I, Item 1, "Business" under "Company Overview-Operating Policies and Restrictions" in our annual Report on Form 10-K for the year ended December 31, 2013. Our investment policy permits investments in any type of Agency MBS and investment grade non-Agency MBS, legacy securitized mortgage loans, and legacy whole loans.

Since 2008 we have invested primarily in higher credit quality and shorter duration investments. When we have purchased longer duration investments, we have generally reduced the duration risk on these investments through our hedging strategy as discussed further below.

RMBS. Our Agency RMBS investments include MBS collateralized by adjustable-rate mortgage loans ("ARMS"), which have interest rates that generally will adjust at least annually to an increment over a specified interest rate index, and hybrid adjustable-rate mortgage loans ("hybrid ARMs"), which are loans that have a fixed rate of interest for a specified period (typically three to ten years) and then adjust their interest rate at least annually to an increment over a specified interest rate index as further discussed below. Agency ARMs also include hybrid Agency ARMs that are past their fixed-rate periods or within twelve months of their initial reset period. We may also invest in fixed-rate Agency RMBS from time to time. Additionally, we invest in non-Agency RMBS which generally resemble similar types of Agency ARMs, but lack a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity.

20

Interest rates on loans collateralizing Agency and non-Agency ARMs are based on specific index rates, such as the London Interbank Offered Rate, or LIBOR, the one-year constant maturity treasury rate, or CMT, the Federal Reserve U.S. 12-month cumulative average one-year CMT, or MTA, or the 11th District Cost of Funds Index, or COFI. These loans will typically have interim and lifetime caps on interest rate adjustments, or interest rate caps, limiting the amount that the rates on these loans may reset in any given period.

CMBS. Our Agency and non-Agency CMBS are collateralized by first mortgage loans and are substantially comprised of fixed-rate securities. The majority of the loans collateralizing our CMBS are secured by multifamily properties. Typically these loans have some form of prepayment protection provisions (such as prepayment lock-out) or prepayment compensation provisions (such as yield maintenance or prepayment penalty). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay.

CMBS IO. A portion of our Agency and non-Agency CMBS also include IO securities which represent the right to receive excess interest payments (but not principal cash flows) based on the underlying unpaid principal balance of the underlying pool of mortgage loans. As these securities have no principal associated with them, the interest payments received are based on the unpaid principal balance (often referred to as the notional amount) of the underlying pool of mortgage loans. CMBS IO securities generally have some level of prepayment protection in the form of lock-outs, prepayment penalties, or yield maintenance associated with the underlying loans similar to CMBS described above.

Factors that Affect Our Results of Operations and Financial Condition

The performance of our investment portfolio, including the amount of net interest income we earn and fluctuations in investment values, will depend on multiple factors, many of which are beyond our control. These factors include, but are not limited to, the absolute level of interest rates, trends of interest rates, the relative steepness of interest rate curves, prepayment rates on our investments, competition for investments, economic conditions and their impact on the credit performance of our investments (including multifamily, residential and commercial mortgage markets), and market required yields as reflected by market credit spreads. In addition, the performance of our investment portfolio, the cost and availability of financing and the availability of investments at acceptable return levels could be influenced by actions and policy measures of the U.S. government including the Federal Housing Finance Administration, the U. S. Department of the Treasury (the "Treasury"), and the Board of Governors of the Federal Reserve System (the "Federal Reserve").

Our business model may also be impacted by other factors such as the availability and cost of financing and the state of the overall credit markets. Reductions in the availability of financing for our investments could significantly impact our business and force us to sell assets that we otherwise would not sell, potentially at losses or at amounts below their true fair value. Other factors also impacting our business include changes in regulatory requirements, including requirements to qualify for registration under the Investment Company Act of 1940 and REIT requirements.

Investing in mortgage-related securities while using leverage to increase our return on shareholders' capital subjects us to a number of risks including interest rate risk, prepayment and reinvestment risk, credit risk, market value risk and liquidity risk, which are discussed in "Liquidity and Capital Resources" within this Item 2 and Part I, Item 3 of this Quarterly Report on Form 10-Q as well as in Item 1A, "Risk Factors" of Part I, and in Item 7A, "Quantitative and Qualitative Disclosures about Market Risk" of Part II of our Annual Report on Form 10-K for the year ended December 31, 2013. Please see these Items for a detailed discussion of these risks and the potential impact on our results of operations and financial condition.

Non-GAAP Financial Measures

In addition to our operating results presented in accordance with GAAP, this Quarterly Report on Form 10-Q contains certain non-GAAP financial measures. The following descriptions are for the non-GAAP measures contained herein which management has included because we believe these measures may be important to investors and present useful information about the Company's performance:

21

•Core net operating income to common shareholders equals GAAP net income to common shareholders adjusted for amortization of accumulated other comprehensive loss on de-designated cash flow hedges included in GAAP interest expense, net change in fair value of derivative instruments which includes gains and losses on terminated derivative instruments (if applicable), gains and losses on sales of investments, and fair value adjustments on investments not classified as available for sale.

•Effective borrowing costs equals GAAP interest expense excluding the amortization of accumulated other comprehensive loss on interest rate swaps de-designated as cash flow hedges on June 30, 2013 plus net periodic interest costs on derivative instruments (including accrued amounts) which are not already included in GAAP interest expense.

•Adjusted net interest income equals GAAP net interest income less effective borrowing costs.

•Adjusted net interest spread equals average annualized yields on investments less effective borrowing costs.

Schedules reconciling these non-GAAP financial measures to GAAP financial measures are provided in "Results of Operations" within Part 1, Item 2 of this Quarterly Report on Form 10-Q. Management believes these non-GAAP financial measures are useful because they provide investors greater transparency to the information we use in our financial and operational decision-making processes. Management also believes the presentation of these measures, when analyzed in conjunction with the our GAAP operating results, allows investors to more effectively evaluate and compare our performance to that of our peers, particularly those competitors that continue to use cash flow hedge accounting in reporting their financial results, as well as to our performance in periods prior to discontinuing cash flow hedge accounting. However, because these non-GAAP financial measures exclude certain items used to compute GAAP net (loss) income to common shareholders and GAAP interest expense, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, our GAAP results as reported in our consolidated statements of comprehensive income. In addition, because not all companies use identical calculations, our presentation of core net operating income, effective borrowing costs, adjusted net interest income, and adjusted net interest spread may not be comparable to other similarly-titled measures of other companies.

Highlights of the First Quarter of 2014

During the first quarter of 2014, credit spreads tightened across fixed income markets and the U.S Treasury curve flattened as markets seemed to adjust to Janet Yellen as the new Chair of the Federal Reserve and as a result of somewhat tepid economic data. The combination of tighter credit spreads and lower rates helped increase our book value per common share by $0.18, or slightly more than 2%, to $8.87 from $8.69. We also earned $0.25 per common share on a core net operating income basis (a non-GAAP measure) versus $0.29 per common share in the fourth quarter of 2013, as general and administrative expenses in the fourth quarter reflected the reversal of $1.4 million in incentive compensation accruals. We declared a dividend of $0.25, slightly lower than our fourth quarter dividend of $0.27. In addition, we continued to reduce the overall leverage on our balance sheet as we maintained a cautious stance with respect to reinvestments of principal and interest received on our portfolio.

Our adjusted net interest spread (a non-GAAP measure) increased 0.11% for the first quarter of 2014 compared to fourth quarter of 2013. This increase in adjusted net interest spread resulted from a 0.02% increase in average annualized effective yields on our assets as well as a 0.09% decline in the effective borrowing rate (a non-GAAP measure) of financing our assets. We continue to maintain a modeled duration gap (a measure of the sensitivity of our investments and derivative instruments to changes in interest rates) at the higher end of our 0.5-1.5 years targeted range. Our duration gap exposure is generally in the one-to-three year maturities, which are generally more sensitive to actual or expected changes in the targeted federal funds rate.

The following table summarizes the average annualized effective yield by type of MBS investment for the first quarter of 2014 and for each of the preceding four quarters:

22

	Three Months Ended
	March 31, 2014	December 31, 2013	September 30, 2013	June 30, 2013	March 31, 2013
Average annualized effective yield:
RMBS	1.87%	1.85%	1.99%	1.91%	2.05%
CMBS	4.61%	4.65%	4.78%	4.75%	4.73%
CMBS IO	4.21%	4.47%	4.41%	4.53%	4.61%
All other investments	5.17%	5.26%	5.36%	5.44%	5.36%
Total average annualized effective yield	2.74%	2.72%	2.82%	2.86%	3.04%
Costs of financing	(0.87)%	(0.90)%	(0.88)%	(1.11)%	(1.15)%
Net interest spread	1.87%	1.82%	1.94%	1.75%	1.89%
Effective borrowing cost (1)	(0.86)%	(0.95)%	(1.17)%	(1.14)%	(1.17)%
Adjusted net interest spread (1)	1.88%	1.77%	1.65%	1.72%	1.87%

(1) Represents a non-GAAP financial measure. Please refer to the discussion above regarding the use of non-GAAP financial measures and to the corresponding reconciliations of GAAP to non-GAAP financial measures provided in "Results of Operations" within this Item 2.

Trends and Recent Market Impacts

There are certain conditions and prospective trends in the marketplace that have impacted our current financial condition and results of operations and which may continue to impact us in the future. The following provides a discussion of conditions and trends that had significant developments during the first quarter of 2014 or are new conditions and trends that are important to our financial condition and results of operations.

Federal Reserve Monetary Policy

The Federal Open Market Committee ("FOMC") continues its purchase of U.S. Treasury and fixed-rate Agency MBS under its asset purchase program known as "QE3". The FOMC beginning in May 2014 will be purchasing $45 billion per month in securities down from a high of $85 billion per month in 2013. The FOMC has reduced its targeted purchases of Treasury and Agency MBS by $10 billion per month as announced at its regularly scheduled meetings. The FOMC has indicated that improvements in the underlying strength of the broader economy as evidenced by continued improvement in economic activity and labor market conditions support the reduction in the purchases of securities despite the negative impact on growth from adverse winter weather conditions in the first quarter of 2014. In its March 2014 meeting, the FOMC shifted its guidance on the future path of interest rate policy. Previously, the FOMC had set targets for inflation and unemployment that were intended to communicate to the markets the economic conditions in which the FOMC may change its policy with respect to the federal funds target rate. The Committee revised its guidance at its March 2014 meeting, removing the targeted inflation and unemployment rate. The FOMC further noted that it will continue to monitor income information on economic and financial developments and will continue its purchases of Treasury securities and Agency MBS, and employ its other policy tools as appropriate, until the outlook for the labor market has improved substantially in a context of price stability. In its latest statement, the FOMC reiterated its commitment to maintaining a highly accommodative stance of monetary policy for a considerable time after the asset purchase program ends. In determining how long to maintain the current 0% to 0.25% target range for the federal funds rate, the FOMC noted that it will assess progress--both realized and expected--toward its objectives of maximum employment and 2% inflation. It was noted that this assessment will take into account a wide range of information, including measures of labor market conditions, indicators of inflation pressures and inflation expectations, and readings on financial developments. The FOMC noted that when it decides to begin to remove policy accommodation, it will take a balanced approach consistent with its longer-run goals of maximum employment and inflation of 2%.Market participants are currently forecasting an end to asset purchases by the FOMC in 2014 and the highest probability of an increase in the targeted federal funds rate sometime in the second quarter of 2015.

23

Asset Credit Spreads and Competition for Assets

Asset credit spreads are defined as the difference between the yields on securities with credit risk and yields on benchmark securities, and that reflects the relative riskiness of the securities versus the benchmark. Changes in asset credit spreads result from the expansion or contraction of the perceived riskiness of an investment versus its benchmark. As noted in the table shown below, asset credit spreads widened dramatically in the second quarter of 2013, but have tightened since, in part due to Federal Reserve policy, supply considerations, and overall market liquidity. Spreads continued to tighten in the first quarter of 2014 for the same reasons and also from perceived dovish commentary from FOMC officials. The following table provides various estimated market credit spreads on categories of assets owned by the Company at the end of each of the last four quarters:

(amounts in basis points)	March 31, 2014		December 31, 2013		September 30, 2013		June 30, 2013
Hybrid ARM 5/1 (2.0% coupon) spread to Treasuries		21		30		40		45
Hybrid ARM 10/1 (2.5% coupon) spread to Treasuries		57		76		80		75
Agency CMBS spread to interest rate swaps		50		58		72		92
'A'-rated CMBS spread to interest rate swaps		190		220		255		287
Agency CMBS IO spread to Treasuries		155		165		200		200

GSE Reform

Policy makers in Washington DC continue to debate the future of Fannie Mae and Freddie Mac's participation in the U.S. mortgage market. Several bills have been introduced in the U.S. Senate and the U.S. House of Representatives regarding the reform and/or dissolution of the GSEs. Any changes to the structure of the GSEs, or the revocations of their charters, if enacted, may have broad adverse implications for the MBS market and our business, results of operations, and financial condition. We expect such proposals to be the subject of significant discussion, and it is not yet possible to determine whether such proposals will be enacted. While we expect GSE reform to be a multi-year process, it is possible that new types of Agency MBS could be proposed and sold by Fannie Mae and Freddie Mac in the near term that are structured differently from current Agency MBS. This may have the effect of reducing the amount of available investment opportunities for the Company. For further discussion of the uncertainties and risks related to GSE reform, please refer to "Risk Factors" contained within Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013.

Regulatory Uncertainty and Reform

Certain rules recently adopted or proposed by regulators of financial institutions require such financial institutions to maintain minimum amounts of capital relative to their assets. Final rules were adopted on May 1, 2014 by the Federal Reserve, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency to strengthen the leverage ratio standards for the largest, most systemically significant U.S. banking organizations defined as bank holding companies with more than $700 billion in consolidated total assets or $10 trillion in assets under custody. Under the proposal, these entities would be required to maintain a tier 1 capital leverage buffer of at least 2 percent above the minimum supplementary leverage ratio requirement of 3 percent, for a total of 5 percent. Such amount is in excess of current required capital levels for these institutions and could force reductions in overall leverage, including repurchase agreement financing, by these institutions in order to comply with the supplemental leverage ratio requirement, which could in turn limit the amount available for us to borrow or could increase our overall cost of financing. There are various other recently adopted or proposed rules that could impact all regulated financial institutions in ways that may impact our ability to access financing.

In addition, the Federal Reserve has expressed concern over the generally unregulated nature of short-term wholesale funding markets including the repurchase agreement markets. In a speech to the Federal Reserve Bank of Atlanta Financial Markets Conference on April 15, 2014, Ms. Yellen, Chair of the Federal Reserve, noted that the Federal Reserve is actively considering additional measures that could address risks in the short-term wholesale funding markets in the event of a crisis such as was experienced in 2008 and 2009.Various other suggestions have been made including imposing capital surcharges and guarantees as well as money market mutual fund reform (money market mutual funds are a large supplier of liquidity to the repurchase

24

markets). The outcome of any of these suggestions are uncertain but any capital surcharges (including to fund guarantees for certain types of financing transactions) or other reductions in repurchase agreement availability could have a material effect on the availability and cost of financing. In response to these regulatory efforts, we are maintaining a diverse counterparty funding base and also seeking to diversify our investment funding.

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of our financial condition and results of operations are based in large part upon our consolidated financial statements, which have been prepared in accordance with GAAP.  The preparation of our consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities. We base these estimates and judgments on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual results, however, may differ from the estimated amounts we have recorded. The discussion and analysis of our financial condition and results of operations also consider certain non-GAAP measures as described in "Executive Overview".

Critical accounting policies are defined as those that require management's most difficult, subjective or complex judgments, and which may result in materially different results under different assumptions and conditions. Our accounting policies that require the most significant management estimates, judgments, or assumptions, or that management believes includes the most significant uncertainties, and are considered most critical to our results of operations or financial position relate to fair value measurements, amortization of investment premiums, and other-than-temporary impairments. Our critical accounting policies are discussed in our Annual Report on Form 10-K for the year ended December 31, 2013 under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies”. There have been no significant changes in our critical accounting policies during the three months ended March 31, 2014.

FINANCIAL CONDITION

We invest primarily in Agency and non-Agency MBS, including RMBS, CMBS and CMBS IO securities. The following tables outline our asset allocation based on fair value as of March 31, 2014 and as of the end of each of the four preceding quarters:

	March 31, 2014	December 31, 2013	September 30, 2013	June 30, 2013	March 31, 2013
Agency MBS	83.6%	85.5%	86.3%	85.9%	84.9%
Non-Agency MBS	15.0%	13.1%	12.3%	12.6%	13.6%
Other investments	1.4%	1.4%	1.5%	1.5%	1.5%

	March 31, 2014	December 31, 2013	September 30, 2013	June 30, 2013	March 31, 2013
RMBS	64.5%	67.3%	68.5%	67.9%	65.0%
CMBS	18.5%	17.7%	17.2%	17.4%	19.3%
CMBS IO	17.0%	15.0%	14.3%	14.7%	15.7%

As shown above, our asset allocation is more heavily weighted toward Agency MBS which have a guaranty of principal payment by an agency of the U.S. government or a GSE such as Fannie Mae and Freddie Mac, and therefore carry less credit risk than our non-Agency MBS which have no such guaranty of payment. The majority of our Agency MBS investments are RMBS predominantly collateralized by variable-rate mortgage loans. Agency MBS also includes CMBS IO securities rated 'AAA' which are issued by securitization trusts sponsored by Fannie Mae, Freddie Mac and Ginnie Mae. The majority of our non-Agency MBS investments are fixed-rate CMBS and CMBS IO. During the first quarter of 2014, we conservatively managed our investment portfolio and leverage and retained a portion of our portfolio paydowns; we invested the remainder of our portfolio paydowns primarily in non-Agency CMBS and CMBS IO. These investments provided more attractive risk-adjusted returns during the first quarter, and we anticipate that trend continuing into the second quarter.

25

Agency MBS

Our investments in Agency RMBS are collateralized primarily by ARMs and hybrid ARMs. Our investments in Agency CMBS and CMBS IO are collateralized by fixed rate mortgage loans which generally have some form of prepayment protection provisions (such as prepayment lock-outs) or prepayment compensation provisions (such as yield maintenance or prepayment penalties).

Activity related to our Agency MBS for the three months ended March 31, 2014 is as follows:

($ in thousands)	RMBS			CMBS			CMBS IO (1)			Total
Balance as of January 1, 2014	$	2,692,150		$	331,501		$	460,327		$	3,483,978
Purchases	10,247			16,171			25,389			51,807
Principal payments	(113,207		)	(1,399		)	—			(114,606		)
Sales	(56,801		)	—			(326		)	(57,127		)
Change in net unrealized gain	14,908			966			3,160			19,034
Net premium amortization	(7,995		)	(1,027		)	(17,305		)	(26,327		)
Balance as of March 31, 2014	$	2,539,302		$	346,212		$	471,245		$	3,356,759

(1) Amounts shown for CMBS IO represent premium only and exclude underlying notional values.

Our investment in Agency MBS as of March 31, 2014 has decreased slightly since December 31, 2013 as our principal payments and sales have outpaced our purchases. In recent quarters, our purchases of Agency RMBS have slowed due to a lower supply of attractive purchases at premiums acceptable to us while our purchases of Agency CMBS and CMBS IO have increased quarter over quarter due to their better absolute return and value relative to Agency RMBS in the current market environment. Unlike Agency RMBS, Agency CMBS and CMBS IO generally have prepayment protection provisions, therefore management views these MBS as having lower prepayment risk. Please refer to "Prepayment Risk" within Item 3, "Quantitative and Qualitative Disclosures About Market Risk" contained within this Quarterly Report on Form 10-Q for further discussion.

As of March 31, 2014, 75% of our Agency MBS issued securities are variable-rate MBS with the remainder fixed-rate MBS compared to 77% variable-rate Agency MBS as of December 31, 2013. As of March 31, 2014, approximately 97% of our variable-rate Agency RMBS portfolio resets based on one-year LIBOR plus a weighted average rate of approximately 1.78%. The following table presents the weighted average coupon (“WAC”) by weighted average months to reset ("MTR") for the variable-rate portion of our Agency RMBS portfolio based on par value as of March 31, 2014 and December 31, 2013:

	March 31, 2014						December 31, 2013
($ in thousands)	Par Value		Reset Margin		WAC		Par Value		Reset Margin		WAC
0-12 MTR	$	549,224	1.77	%	3.02	%	$	575,763	1.79	%	2.97	%
13-36 MTR	221,399		1.87	%	3.98	%	276,862		1.84	%	3.89	%
37-60 MTR	709,381		1.80	%	3.38	%	619,887		1.79	%	3.57	%
61-84 MTR	94,345		1.81	%	3.74	%	171,839		1.80	%	3.01	%
85-120 MTR	845,500		1.73	%	2.92	%	928,580		1.74	%	2.99	%
ARMs and Hybrid ARMs	2,419,849		1.78	%	3.21	%	2,572,931		1.78	%	3.22	%
Fixed	18,284				2.51	%	$	18,637			2.51	%
Total	$	2,438,133			3.20	%	$	2,591,568			3.22	%

During the first quarter of 2014, we received principal payments (both scheduled and unscheduled) on our Agency RMBS of $113.2 million versus $212.0 million for the first quarter of 2013. Principal payments received on our investments have been decreasing quarter over quarter due to lower prepayments, which is due to higher mortgage rates impacting refinancing activity as noted in the shown by the weekly Mortgage Bankers Association Refinancing Index. Constant prepayment rate ("CPR") is a

26

measure of the annualized percentage of the principal balance of a pool of loans that is expected to be paid off prematurely in a given period. The rate at which we amortize the premiums we pay for our investments is impacted by our current and anticipated CPR. Please refer to the "Prepayment and Reinvestment Risk" section of Item 3, "Quantitative and Qualitative Disclosures About Market Risk" for more information. The following table provides the CPRs on our Agency RMBS for the periods indicated:

	Three Months Ended
	March 31, 2014		December 31, 2013		September 30, 2013		June 30, 2013		March 31, 2013
Agency RMBS	12.7	%	14.3	%	23.8	%	25.7	%	24.8	%

Non-Agency MBS

Our purchases of non-Agency MBS are primarily investment grade securities (rated 'BBB' or better by at least one nationally recognized statistical ratings organizations). We typically purchase newer issue non-Agency MBS and have not generally purchased heavily discounted seasoned MBS. None of the non-Agency MBS in our portfolio as of March 31, 2014 or as of December 31, 2013 were purchased at a substantial discount.

Activity related to our non-Agency MBS for the three months ended March 31, 2014 is as follows:

($ in thousands)	RMBS			CMBS			CMBS IO (1)			Total
Balance as of January 1, 2014	$	13,765		$	369,281		$	151,137		$	534,183
Purchases	3,500			12,895			65,076			81,471
Principal payments	(1,891		)	(7,265		)	—			(9,156		)
Sales	—			(5,978		)	—			(5,978		)
Change in net unrealized gain	(135		)	6,751			1,607			8,223
Net accretion (amortization)	331			311			(6,293		)	(5,651		)
Balance as of March 31, 2014	$	15,570		$	375,995		$	211,527		$	603,092

(1) Amounts shown for CMBS IO represent premium only and exclude underlying notional values.

Our investment in non-Agency MBS increased approximately 13% from December 31, 2013 to March 31, 2014. The majority of that increase is due to purchases of non-Agency CMBS IO which offered risk adjusted returns that were more attractive versus other investment opportunities.

The following table shows purchase price and related premium (discount) on purchases of our non-Agency MBS during the first quarter of 2014 by credit rating at the time of purchase:

	Three Months Ended
	March 31, 2014
Credit Rating At Purchase	Purchase Price		Premium (Discount)
($ in thousands)
Non-Agency CMBS IO rated AAA (1)	$	65,076	$	65,076
Non-Agency CMBS rated A or BBB	12,895		(375		)
Non-Agency RMBS non-investment grade	3,500		—
Total purchases	$	81,471	$	64,701

(1) For CMBS IO, premium is equal to purchase price as these securities have no principal associated with them. Notional amount of these securities purchased during the three months ended March 31, 2014 was approximately $797.4 million.

27

Management does not anticipate any material credit losses on non-Agency MBS that were purchased at a discount during the three months ended March 31, 2014.

The weighted average months to maturity for all of our non-Agency CMBS and CMBS IO securities together as of March 31, 2014 was 76 months with 89% having origination dates of 2009 or later, and the remainder prior to 2000. Our non-Agency CMBS investments consist primarily of Freddie Mac Multifamily K Certificates on pools of recently originated multifamily mortgage loans. These certificates are not guaranteed by Freddie Mac, and, therefore, repayment is based solely on the performance of the underlying pool of loans.

The following table presents information for our non-Agency CMBS and CMBS IO investments by credit rating as of March 31, 2014 and December 31, 2013:

	March 31, 2014
	Non-Agency CMBS						Non-Agency CMBS IO
($ in thousands)	Fair Value		Net Unrealized Gain (Loss)		Related Borrowings		Fair Value		Net Unrealized Gain		Related Borrowings
AAA	$	—	$	—	$	—	$	210,184	$	2,168	$	149,089
AA	75,990		2,091		69,983		1,343		58		16
A	251,959		16,161		204,961		—		—		—
Below A/Not Rated	48,047		354		34,454		—		—		—
	$	375,996	$	18,606	$	309,398	$	211,527	$	2,226	$	149,105

	December 31, 2013
	Non-Agency CMBS							Non-Agency CMBS IO
($ in thousands)	Fair Value		Net Unrealized Gain			Related Borrowings		Fair Value		Net Unrealized Gain		Related Borrowings
AAA	$	40,379	$	2,126		$	35,637	$	149,692	$	555	$	106,787
AA	40,022		62			35,402		1,445		65		16
A	237,261		10,307			194,952		—		—		—
Below A/Not Rated	51,619		(641		)	37,683		—		—		—
	$	369,281	$	11,854		$	303,674	$	151,137	$	620	$	106,803

The following table presents the geographic diversification of the collateral underlying our non-Agency CMBS by the top 5 states as of March 31, 2014 compared to December 31, 2013:

	March 31, 2014				December 31, 2013
($ in thousands)	Market Value of Collateral		Percentage		Market Value of Collateral		Percentage
Florida	$	78,271	13.1	%	$	82,269	13.9	%
California	74,785		12.5	%	81,353		13.7	%
Texas	63,821		10.7	%	69,044		11.6	%
New York	37,833		6.3	%	32,240		5.4	%
Virginia	29,235		4.9	%	30,784		5.2	%
Remaining states (not exceeding 4.7% individually)	312,347		52.5	%	297,398		50.2	%
	$	596,292	100.0	%	$	593,088	100.0	%

28

Derivative Assets and Liabilities

Our derivative assets and liabilities consist of interest rate swap agreements and Eurodollar futures, both of which are viewed by us as economic hedges of our exposure to fluctuations in interest rates. Effective June 30, 2013 we voluntarily discontinued cash flow hedge accounting for all interest rate swaps that were previously designated as cash flow hedges under GAAP because certain accounting requirements to qualify for cash flow hedge treatment limited our ability to extend maturity dates for our repurchase agreements beyond 30 days.

As a result of discontinuing cash flow hedge accounting and as a result of the additional cost associated with the Dodd-Frank requirements pertaining to interest rate swaps, we began using Eurodollar futures to mitigate interest rate risk as part of managing variability at specific points of the LIBOR curve. Eurodollar futures represent forward starting 3-month LIBOR contracts and allow us to synthetically replicate swap curves and/or hedge specific points on the swap curve where we may have duration risk by shorting contracts at various points of the LIBOR curve. We also entered into forward-starting interest rate derivatives, partly due to the Federal Reserve's policy with respect to a sustained low federal funds target rate which heavily influences the interest costs on our borrowings. As of March 31, 2014, the weighted average notional amount of interest rate derivatives instruments that will be effective for future periods are shown in the following table:

($ in thousands)	Interest Rate Swaps		Eurodollar Futures		Total		Weighted-Average Rate (1)
Effective 2014	$	800,245	$	—	$	800,245	1.58	%
Effective 2015	850,000		—		850,000		1.61	%
Effective 2016	850,000		394,393		1,244,393		1.88	%
Effective 2017	738,887		1,013,056		1,751,943		2.47	%
Effective 2018	665,000		507,222		1,172,222		2.69	%
Effective 2019	338,223		224,890		563,113		2.99	%
Effective 2020	266,277		158,860		425,137		3.10	%
Effective 2021	191,319		—		191,319		2.13	%
Effective 2022	180,000		—		180,000		2.13	%
Effective 2023	159,478		—		159,478		2.15	%
Effective 2024	38,874		—		38,874		2.18	%

(1) Weighted average rate is based on the weighted average notional outstanding.

Please refer to Note 5 of the Notes to the Unaudited Consolidated Financial Statements contained with this Quarterly Report on Form 10-Q as well as "Loss on Derivative Instruments, Net" within "Results of Operations" contained within this Item 2 for additional information related to our derivative assets and liabilities.

Repurchase Agreements

Repurchase agreements decreased $95.2 million from December 31, 2013 to March 31, 2014. During the first quarter of 2014, we continued to lower our leverage to conservatively position our portfolio in the current market environment, an effort that began in part due to increased market volatility experienced beginning in the second quarter of 2013. The combined weighted average original term to maturity for our repurchase agreements decreased to 93 days as of March 31, 2014 from 114 days as of December 31, 2013. We chose to shorten maturities during the first quarter in order to reduce our borrowing costs given the improved liquidity in the repurchase agreement funding market during the first quarter of 2014. Please refer to Note 4 of the Notes to the Unaudited Consolidated Financial Statements contained within this Quarterly Report on Form 10-Q as well as "Interest Expense, Annualized Cost of Funds, and Effective Borrowings Costs" within "Results of Operations" and “Liquidity and Capital Resources” contained within this Item 2 for additional information relating to our repurchase agreements.

29

Shareholders' Equity

Shareholders' equity increased $13.1 million since December 31, 2013 primarily as a result of an increase of $29.6 million in AOCI. The majority of that increase resulted from increases in the fair value of our MBS investments, which are detailed in the table below. Additionally, stock issuances, net of capitalized stock issuance costs and other items, increased shareholders' equity by $0.2 million. These increases were offset by a net loss to the common shareholders of $3.0 million and common dividends declared of $13.7 million.

The following table provides detail on the increase in AOCI from changes in fair value of our MBS investments during the three months ended March 31, 2014:

	Three Months Ended
($ in thousands)	March 31, 2014
Agency:
RMBS	$	14,908
CMBS	982
CMBS IO	3,160
Non-Agency:
RMBS	(135		)
CMBS	6,751
CMBS IO	1,606
Total change in fair value of MBS investments, net of net losses on sales of investments realized in net income	27,272
Reclassification adjustment for amortization of de-designated cash flow hedges	2,288
Increase in AOCI	$	29,560

Supplemental Information

The tables below present the allocation of our shareholders' equity to our assets and liabilities. The allocation of shareholders' equity is determined by subtracting the associated financing for each asset from that asset's carrying basis:

	As of March 31, 2014
($ in thousands)	Asset Carrying Basis		Associated Financing(1)/ Liability Carrying Basis		Allocated Shareholders’ Equity		% of Shareholders’ Equity
Agency MBS	$	3,356,759	$	2,998,479	$	358,280	59.8	%
Non-Agency MBS	603,093		486,459		116,634		19.5	%
Mortgage loans held for investment, net	53,804		29,086		24,718		4.1	%
Derivative assets (liabilities)	12,064		11,137		927		0.2	%
Cash and cash equivalents	61,168		—		61,168		10.2	%
Restricted cash	18,242		—		18,242		3.0	%
Other assets/other liabilities	39,152		20,106		19,046		3.2	%
	$	4,144,282	$	3,545,267	$	599,015	100.0	%

30

	As of December 31, 2013
($ in thousands)	Asset Carrying Basis		Associated Financing(1)/ Liability Carrying Basis		Allocated Shareholders’ Equity		% of Shareholders’ Equity
Agency MBS	$	3,483,978	$	3,149,470	$	334,508	57.1	%
Non-Agency MBS	534,183		420,991		113,192		19.3	%
Mortgage loans held for investment, net	55,423		33,565		21,858		3.7	%
Derivative assets (liabilities)	18,488		6,681		11,807		2.0	%
Restricted cash	69,330		—		69,330		11.8	%
Cash and cash equivalents	13,385		—		13,385		2.4	%
Other assets/other liabilities	42,350		20,554		21,796		3.7	%
	$	4,217,137	$	3,631,261	$	585,876	100.0	%

 (1) Associated financing related to investments includes repurchase agreements as well as payables pending for unsettled trades, if any, as of the date indicated, and non-recourse collateralized financing. Associated financing for derivative instruments represents the fair value of the derivative instruments in a liability position.

The tables below present the allocation of our invested capital by type of investment:

	As of March 31, 2014
($ in thousands)	Asset Carrying Basis		Associated Financing		Invested Capital Allocation		% of Allocated Invested Capital
RMBS and loans	$	2,588,739	$	2,386,707	$	202,032	40.4	%
CMBS and loans	742,145		579,938		162,207		32.5	%
CMBS IO	682,772		547,379		135,393		27.1	%
	$	4,013,656	$	3,514,024	$	499,632	100.0	%

	As of December 31, 2013
($ in thousands)	Asset Carrying Basis		Associated Financing		Invested Capital Allocation		% of Allocated Invested Capital
RMBS and loans	$	2,741,124	$	2,558,395	$	182,729	38.9	%
CMBS and loans	720,996		569,123		151,873		32.4	%
CMBS IO	611,464		476,508		134,956		28.7	%
	$	4,073,584	$	3,604,026	$	469,558	100.0	%

31

RESULTS OF OPERATIONS

The discussions within this section of Item 2 and other portions of this Quarterly Report on Form 10-Q include non-GAAP financial measures which exclude certain GAAP items. Please read the section "Non-GAAP Financial Measures" contained in Executive Overview of this Item 2 for additional important information.

Net income and core net operating income

The following table presents a reconciliation of our GAAP net (loss) income to our core net operating income for the periods presented:

	Three Months Ended
	March 31,
($ in thousands, except per share amounts)	2014			2013
GAAP net (loss) income to common shareholders	$	(3,028	)	$	18,381
Amortization of de-designated cash flow hedges (1)	2,288			—
Change in fair value on derivative instruments, net (2)	11,211			(157		)
Loss (gain) on sale of investments, net	3,307			(1,391		)
Fair value adjustments, net	(32		)	140
Core net operating income to common shareholders	$	13,746		$	16,973
Core net operating income to common shareholders per share	$	0.25		$	0.31

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Represents net realized and unrealized gains and losses on derivatives and excludes net periodic interest costs made on these instruments.

Our GAAP net loss to common shareholders for the three months ended March 31, 2014 included a decrease of $2.5 million in net interest income compared to the first quarter of 2013, which resulted primarily from lower effective yields for the three months ended March 31, 2014 compared to the same period in 2013. In addition, our GAAP net loss to common shareholders for the first quarter of 2014 included a net loss on sale of investments of $3.3 million compared to a net gain of $1.4 million for the same period in 2013. In general, market prices for MBS were lower in the first quarter of 2014 versus 2013, and we sold Agency RMBS during the first quarter of 2014 as a part of portfolio repositioning. Loss on derivative instruments, net for the three months ended March 31, 2014 was $13.4 million higher than the same period in 2013 as the Company discontinued hedge accounting in the second quarter of 2013. Subsequently, all changes in fair value of these instruments are recorded within "net (loss) income" on the Company's consolidated statements of comprehensive income.

Core net operating income to common shareholders (a non-GAAP measure) decreased $3.3 million for the first quarter of 2014 compared to the first quarter of 2013 primarily because of lower adjusted net interest income of $2.3 million. Lower adjusted net interest income resulted primarily from lower effective yields as mentioned above. Additionally, our general and administrative expenses were $0.3 million higher for first quarter of 2014 compared to the first quarter of 2013 primarily because of the addition of new employees since March 31, 2013. The discussions that follow provide details for each of these line items as well as others on the consolidated statements of comprehensive income.

Interest Income and Asset Yields

The following tables present interest income and weighted average yields by type of MBS investment for the periods indicated:

32

	Three Months Ended
	March 31,
	2014						2013
($ in thousands)	Interest Income		Average Balance (1)		Effective Yield (2)		Interest Income		Average Balance (1)		Effective Yield (2)
Agency RMBS	$	11,895	$	2,636,227	1.84	%	$	13,417	$	2,564,732	2.04	%
Agency CMBS	2,870		318,023		3.52	%	3,033		331,780		3.60	%
Agency CMBS IO	4,828		452,099		4.25	%	7,718		560,329		4.59	%
Total Agency	19,593		3,406,349		2.32	%	24,168		3,456,841		2.60	%
Non-Agency RMBS	508		15,588		6.64	%	$	140	$	10,024	5.61	%
Non-Agency CMBS	5,043		361,391		5.56	%	6,466		455,334		5.55	%
Non-Agency CMBS IO	1,758		162,957		4.12	%	1,265		106,954		4.68	%
Total Non-Agency	7,309		539,936		5.16	%	7,871		572,312		5.39	%
Total MBS portfolio	$	26,902	$	3,946,285	2.71	%	$	32,039	$	4,029,153	3.00	%

(1) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

(2) Effective yields are based on annualized amounts. Recalculation of effective yields may not be possible using data provided because certain components of interest income use a 360-day year for the calculation while others use actual number of days in the year.

The following table presents the estimated impact of changes in average yields and average balances on the decrease in interest income for the three months ended March 31, 2014 compared to the three months ended March 31, 2013:

				Due to Change in
($ in thousands)	Increase (Decrease)			Average Balance			Average Yield
Agency MBS	$	(4,575	)	$	(326	)	$	(4,249	)
Non-Agency MBS	(562		)	(434		)	(128		)
Total	$	(5,137	)	$	(760	)	$	(4,377	)

(1) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

The following table presents the components of our interest income by MBS investment type for the periods indicated:

33

	Three Months Ended
	March 31,
($ in thousands)	2014			2013
Agency MBS:
Gross interest	$	45,921		$	52,016
Net premium amortization	(26,328		)	(27,848		)
Total interest income	$	19,593		$	24,168
Average balance of unamortized premium, net	$	618,144		$	723,881
Non-Agency MBS:
Gross interest	$	13,277		$	11,607
Net premium amortization	(5,968		)	(3,736		)
Total interest income	$	7,309		$	7,871
Average balance of unamortized premium, net	$	144,470		$	89,063

Our interest income from MBS decreased for the three months ended March 31, 2014 compared to the three months ended March 31, 2013 primarily due to a decrease in the effective yields on these assets. Our effective yield on Agency MBS decreased primarily because the weighted average coupon rate (a measure of gross interest income) on our Agency RMBS portfolio was 0.36% lower for the three months ended March 31, 2014 compared to the same period in 2013 due to purchases of Agency RMBS with lower coupons and ARM interest rate resets in a lower rate environment. Our effective yield on non-Agency MBS decreased primarily because we carried a lower average balance of higher yielding non-Agency CMBS versus non-Agency CMBS IO during the three months ended March 31, 2014 compared to the same period in 2013.

Net premium amortization for our Agency MBS decreased approximately $1.5 million for the three months ended March 31, 2014 compared to the same period in 2013. Net premium amortization for our non-Agency MBS increased approximately $2.3 million for the three months ended March 31, 2014 compared to the same period in 2013 due to a higher average balance of premiums. Our purchases of non-Agency MBS since March 31, 2013 have been predominantly CMBS IO for which we pay higher premiums.

Interest Expense, Annualized Cost of Funds, and Effective Borrowing Costs

The following table summarizes the components of interest expense as well as average balances and annualized cost of funds for the periods indicated:

	Three Months Ended
	March 31,
($ in thousands)	2014			2013
Repurchase agreements	$	5,323		$	6,115
Interest rate swap expense from cash flow hedging	—			4,103
Amortization of de-designated cash flow hedges (1)	2,288			—
Non-recourse collateralized financing and other expenses	22			238
Total interest expense	$	7,633		$	10,456
Average balance of repurchase agreements	$	3,497,167		$	3,612,319
Average balance of non-recourse collateralized financing	12,722			29,335
Average balance of borrowings	$	3,509,889		$	3,641,654
Annualized cost of funds (2)	0.87		%	1.15		%

34

(1) Amount recorded in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Rates shown are based on annualized interest expense amounts divided by average balance of borrowings. Recalculation of annualized cost of funds using total interest expense shown in the table may not be possible because certain expense items use a 360-day year for the calculation while others use actual number of days in the year.

The majority of the decrease in our interest expense from repurchase agreement borrowings is due to a significant decrease in the weighted average borrowing rate which was 0.61% for the three months ended March 31, 2014 compared to 0.68% for the same period in 2013. Our repurchase agreement borrowing rates are typically based on shorter-term interest rate indexes, such as one-month LIBOR, which were lower during the first quarter of 2014 compared to the first quarter of 2013.

Total interest expense shown on our consolidated statements of comprehensive income for the three months ended March 31, 2013 includes net periodic interest costs of our derivative instruments while they were designated as cash flow hedges. Effective June 30, 2013, management discontinued the use of cash flow hedge accounting. Subsequent to June 30, 2013, all net periodic interest costs of our derivative instruments are now recorded within "loss on derivative instruments, net" on our consolidated statements of comprehensive income instead of within "interest expense". The following table presents our total net periodic interest costs related to our derivative instruments segregated by their location on our consolidated statements of comprehensive income for the periods indicated:

	Three Months Ended
	March 31,
($ in thousands)	2014		2013
Included in "interest expense" (from cash flow hedging)	$	—	$	4,103
Included in "loss on derivative instruments, net"	2,211		174
Total net periodic interest costs of derivative instruments:	$	2,211	$	4,277

We incurred lower net periodic interest costs from our derivative instruments for the three months ended March 31, 2014 compared to the three months ended March 31, 2013, because we had a lower notional balance of interest rate swaps outstanding during the three months ended March 31, 2014 compared to the three months ended March 31, 2013.

Because our annualized cost of funds does not incorporate our total net periodic interest costs of derivative instruments, management utilizes a non-GAAP financial measure "effective borrowing costs". Although we have elected to discontinue cash flow hedge accounting for our interest rate swaps, we view our interest rate derivative instruments as economic hedges of our exposure to higher interest rates. Effective borrowing costs equal GAAP interest expense less the amortization from de-designated cash flow hedges (which is included in GAAP interest expense) plus any net periodic interest costs of derivative instruments which are not already included in GAAP interest expense as a result of cash flow hedge de-designation. In other words, our effective borrowing costs include all interest expense incurred from our repurchase agreements, non-recourse collateralized financing, and derivative instruments (excluding changes in fair value and amortization of AOCI from cash flow hedge de-designation). The tables below present a reconciliation of GAAP interest expense and annualized costs of funds to our effective borrowing costs and related rates during the periods indicated:

	Three Months
	March 31,
	2014					2013
($ in thousands)	Amount			Rate (4)		Amount		Rate (4)
GAAP interest expense/annualized cost of funds	$	7,633		0.87	%	$	10,456	1.15	%
Amortization of de-designated cash flow hedges (1)	(2,288		)	(0.26	)%	—		—	%
Net periodic interest costs from derivative instruments (2)	2,211			0.25	%	174		0.02	%
Effective borrowing costs/rate	$	7,556		0.86	%	$	10,630	1.17	%
Average balance of borrowings (3)	$	3,509,889				$	3,641,654

35

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "loss on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

(3) Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and securitization financing.

(4) Rates shown are based on annualized interest expense amounts divided by average balance of borrowings. Recalculation of annualized cost of funds and effective borrowing rates using interest expense shown in the table may not be possible because certain expense items use a 360-day year for the calculation while others use actual number of days in the year. 

In summary, our GAAP interest expense/annualized cost of funds and our effective borrowing costs/rate decreased for the three months ended March 31, 2014 compared to the same period in 2013, because we had lower borrowing rates on our repurchase agreement financings and lower net periodic interest costs from our derivative instruments.

Net Interest Income and Net Interest Spread

To adjust for the impact of cash flow hedge de-designation and to make our results more comparable to prior periods and to competitors using cash flow hedge accounting, management uses the non-GAAP financial measures "adjusted net interest income" and "adjusted net interest spread". These measures include total net periodic interest cost of derivative instruments in our net interest income and net interest spread. The following table reconciles GAAP net interest income and related net interest spread to our adjusted net interest income and adjusted net interest spread for the periods indicated:

	Three Months Ended
	March 31,
	2014					2013
($ in thousands)	Amount			Yield		Amount			Yield
GAAP interest income	$	27,640		2.74	%	$	32,982		3.04	%
GAAP interest expense	7,633			0.87	%	10,456			1.15	%
Net interest income/spread	20,007			1.87	%	22,526			1.89	%
Amortization of de-designated cash flow hedges (1)	2,288			0.26	%	—			—	%
Net periodic interest costs of derivative instruments (2)	(2,211		)	(0.25	)%	(174		)	(0.02	)%
Adjusted net interest income/spread	$	20,084		1.88	%	$	22,352		1.87	%
Average interest earning assets (3)	$	4,002,555				$	4,098,681
Average balance of borrowings (4)	$	3,509,889				$	3,641,654

(1) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the amortization of the balance remaining in accumulated other comprehensive loss as of June 30, 2013 as a result of our discontinuation of cash flow hedge accounting.

(2) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "loss on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

(3) Average balances are calculated as a simple average of the daily amortized cost and exclude unrealized gains and losses as well as securities pending settlement if applicable.

(4) Average balances are calculated as a simple average of the daily borrowings outstanding for both repurchase agreement and securitization financing.

Our net interest income and adjusted net interest income decreased for the three months ended March 31, 2014 compared to the three months ended March 31, 2013 due to smaller average interest earning asset balances and the lower effective yields earned on our investments, as discussed above under "Interest Income and Asset Yields". The impact of lower effective yields was

36

partially offset by lower overall annualized cost of funds as discussed above under "Interest Expense, Annualized Cost of Funds, and Effective Borrowing Costs".

Loss on Derivative Instruments, Net

Our "loss on derivative instruments, net" on our consolidated statement of comprehensive income for the three months ended March 31, 2014 includes all net periodic interests costs and changes in fair value incurred during the first quarter of 2014 related to our derivative instruments, which consist of interest rate swaps and Eurodollar futures. As discussed earlier, we discontinued cash flow hedge accounting for all of our interest rate swaps effective June 30, 2013. During the three months ended March 31, 2013, "loss on derivative instruments, net" included net periodic interest costs and changes in fair value for three interest rate swap agreements with a notional balance of $27.0 million and a weighted average pay-fixed rate of 2.88% which we had never designated as cash flow hedges. The net periodic interest costs related to our interest rate swaps designated as cash flow hedges during the three months ended March 31, 2013 were included in "interest expense". The following table provides information on the components of our loss on derivative instruments, net for the periods indicated:

	Three Months Ended
	March 31,
($ in thousands)	2014			2013
Net periodic interest costs of derivative instruments (1)	$	(2,211	)	$	(174	)
Change in fair value of derivative instruments, net	(11,211		)	157
Loss on derivative instruments, net	$	(13,422	)	$	(17	)

(1) Amount equals the net interest payments (including accrued amounts) related to interest rate derivatives during the period which are recorded in "loss on derivative instruments, net" and not already included in "interest expense" in accordance with GAAP.

Loss on derivative instruments, net for the first quarter of 2014 resulted from the overall decline in interest rates during the quarter primarily in the longer end of the Treasury and interest rate swap curves where the preponderance of our derivative instruments are economically hedging our interest rate risk.

(Loss) Gain on Sale of Investments, Net

Sales of our investments occur in the ordinary course of business as a result of portfolio repositioning. The following table provides information related to our (loss) gain on sale of investments, net for the periods indicated:

	Three Months Ended
	March 31,
	2014					2013
($ in thousands)	Amortized cost basis sold		Gain (loss) on sale of investments, net			Amortized cost basis sold		Gain (loss) on sale of investments, net
Type of Investment
Agency RMBS	$	56,801	$	(3,526	)	$	—	$	—
Agency CMBS	—		—			1,960		(8		)
Agency CMBS IO	326		19			18,233		353
Non-Agency CMBS	5,978		200			9,573		1,046
	$	63,105	$	(3,307	)	$	29,766	$	1,391

37

General and Administrative Expenses

General and administrative expenses were $4.1 million for the three months ended March 31, 2014 versus $3.8 million during the three months ended March 31, 2013. The increase is primarily due to higher compensation and benefits expenses related to the addition of our co-Chief Executive Officer at the beginning of the quarter as well as an increase in stock based compensation expense for the amortization of the restricted stock awarded to certain of our executive officers as part of their 2013 performance bonus.

LIQUIDITY AND CAPITAL RESOURCES

 Our primary sources of liquidity include borrowings under repurchase arrangements, monthly principal and interest payments we receive on our investments, and cash. Additional sources may also include proceeds from the sale of investments, equity offerings, issuances of collateralized financings, and payments received from counterparties from interest rate swap agreements.  We use our liquidity to fund our investment purchases and other operating costs, to pay down borrowings, to make payments to counterparties as required under interest rate swap agreements, and to pay dividends on our common stock.

Our available liquid assets as of March 31, 2014 were $200.7 million compared to $208.7 million as of December 31, 2013. As of March 31, 2014, our liquid assets consist of unrestricted cash and cash equivalents of $61.2 million, $131.6 million in unencumbered Agency MBS, and $8.0 million of unrestricted cash collateral received on derivative positions. Unencumbered Agency MBS are considered part of our liquid assets as we may pledge them to lenders and interest rate swap counterparties if we experience a margin call (which is discussed below). We monitor our current and forecasted available liquidity on a daily basis. Our liquid assets may fluctuate from period to period based on our investment activities and whether we have recently raised, but not yet deployed, equity capital. However, we will maintain sufficient liquidity based on the sensitivity analysis and debt-to-equity requirements discussed below, to support our operations and meet our anticipated liquidity needs.

We perform sensitivity analysis on our liquidity based on changes in the value of our investments due to changes in interest rates, credit spreads, lender haircuts and prepayment speeds. We also closely monitor our debt-to-invested equity ratio (which is the ratio of debt financing to invested equity for any investment) as part of our liquidity management process as well as our overall enterprise level debt-to-equity and the ratio of our available liquidity to outstanding repurchase agreement borrowings.  Our current operating policies provide that recourse borrowings including repurchase agreements used to finance investments will be in the range of three (3) to ten (10) times our invested equity capital depending on the investment type. Our maximum target leverage is up to ten (10) times our invested capital for Agency RMBS, eight (8) times for Agency CMBS and five (5) times for Agency CMBS IO. With respect to non-Agency MBS, our maximum target leverage is up to five (5) times our invested capital in non-Agency CMBS and RMBS, and up to four (4) times our invested capital in non-Agency CMBS IO. The maximum targets represent fixed limits for leveraging our investment capital. We may change our leverage targets based on market conditions and our perceptions of the liquidity of our investments.

On an enterprise level basis, our current operating policies limit our total liabilities-to-shareholders' equity to seven (7) times our shareholders' equity. On an enterprise-wide basis, our total liabilities decreased to 5.9 times shareholders' equity as of March 31, 2014 from 6.2 times shareholders' equity as of December 31, 2013. Because market volatility in asset prices since the second quarter of 2013 has increased risk to the Company, we have been reducing our leverage by selling approximately $233.3 million of our assets since June 30, 2013 and limiting the re-investment of principal payments we receive on our investments.

In 2013 and in the first quarter of 2014, we had ample sources of liquidity to fund our activities and operations. The ability to fund our operations in the future depends in large measure on the availability of credit through repurchase agreement financing and the liquidity of our investments. Credit markets in general are stable, and there is ample availability. However, these markets and the liquidity of our investments remain susceptible to exogenous shocks as was experienced in the financial crisis in 2008 and 2009. In addition, in recent quarters U.S. financial regulatory agencies (such as the Office of Financial Research in the U.S. Treasury and the Federal Reserve) have expressed some concern about the stability of repurchase agreement financing for mortgage REITs in a rising interest rate environment, and regulatory reform in the form of certain provisions of the Basel III capital framework and the Dodd-Frank Wall Street Reform and Consumer Protection Act could impact the overall availability of credit. In times of severe market stress, repurchase agreement availability could be rapidly reduced and the terms on which we can borrow could be materially altered, particularly given the focus on these markets by the federal financial and banking regulators. Competition from other REITs, banks, hedge funds, and the federal government for capacity with our repurchase agreement lenders could also reduce

38

our repurchase agreement availability. While we do not anticipate such events in the near term, a reduction in our borrowing capacity could force us to sell assets in order to repay our lenders or could otherwise restrict our ability to operate our business.

Depending on our liquidity levels, the condition of the credit markets, and other factors, we may from time to time consider the issuance of debt, equity, or other securities, the proceeds of which could provide additional liquidity for our operations. While we will attempt to avoid dilutive or otherwise costly issuances, depending on market conditions, in order to manage our liquidity we could be forced to issue equity or debt securities which are dilutive to our capital base or our profitability.

Repurchase Agreements

Our repurchase agreement borrowings generally have a term of between one and six months and carry a rate of interest based on a spread to an index such as LIBOR. As of March 31, 2014, the weighted average original term to maturity was 93 days. Repurchase agreements are generally renewable at the discretion of our lenders and do not contain guaranteed roll-over terms. Given the short-term and uncommitted nature of most of our repurchase agreement financing, we attempt to maintain unused capacity under our existing repurchase agreement credit lines with multiple counterparties which helps protect us in the event of a counterparty's failure to renew existing repurchase agreements either with favorable terms or at all. As of March 31, 2014, we had 31 repurchase agreement counterparties and $3.5 billion in repurchase agreement borrowings outstanding with 21 of those counterparties at a weighted average borrowing rate of 0.59%. As of December 31, 2013, we had $3.6 billion outstanding with 22 counterparties at a weighted average borrowing rate of 0.61%.

For our repurchase agreement borrowings, we are required to post and maintain margin to the lender (i.e., collateral in excess of the repurchase agreement financing) in order to support the amount of the financing. This excess collateral is often referred to as a "haircut" (and which we also refer to as equity at risk). As the collateral pledged is generally MBS, the value of the collateral can fluctuate with changes in market conditions. If the fair value of the collateral falls below the initial haircut amount, the lender has the right to demand additional margin, or collateral, to increase the haircut back to the initial amount. These demands are typically referred to as "margin calls". There is no minimum amount of collateral value decline required before the lender could initiate a margin call, and we typically will experience margin calls for downward fluctuations in collateral values. Declines in the value of investments occur for any number of reasons including but not limited to changes in interest rates, changes in ratings on an investment, changes in actual or perceived liquidity of the investment, or changes in overall market risk perceptions. Additionally, values in Agency RMBS will also decline from the payment delay feature of those securities. Agency RMBS have a payment delay feature whereby Fannie Mae and Freddie Mac announce principal payments on Agency RMBS but do not remit the actual principal payments and interest for 20 days in the case of Fannie Mae and 40 days in the case of Freddie Mac. Because these securities are financed with repurchase agreements, the repurchase agreement lender generally makes a margin call for an amount equal to the product of their advance rate on the repurchase agreement and the announced principal payments on the Agency RMBS. This causes a temporary use of our liquidity to meet the margin call until we receive the principal payments and interest 20 to 40 days later. 

The following table presents certain quantitative information regarding our repurchase agreement borrowings for the periods indicated:

(amounts in thousands)	Balance Outstanding As of Period End		Average Balance Outstanding For the Quarter Ended		Maximum Balance Outstanding During the Quarter Ended
March 31, 2014	$	3,485,544	$	3,497,167	$	3,580,997
December 31, 2013	3,580,754		3,603,477		3,675,290
September 30, 2013	3,674,850		3,836,249		4,071,773
June 30, 2013	4,071,392		4,042,340		4,255,294
March 31, 2013	3,708,255		3,612,319		3,752,000

Generally, our repurchase agreement balances outstanding as of each period end have been closely correlated to our average balances outstanding for each quarter. Since the end of the second quarter of 2013, we have been reducing our repurchase agreement borrowings through sales of assets and have not been fully reinvesting principal payments received on our MBS.

39

The following table discloses our repurchase agreement amounts outstanding (excluding deferred costs related to our committed two-year repurchase facility) and the value of the related collateral pledged by geographic region of our counterparties as of March 31, 2014:

(amounts in thousands)	Amount Outstanding		Market Value of Collateral Pledged
North America	$	2,115,669	$	2,350,820
Asia	854,608		899,558
Europe	515,406		563,977
	$	3,485,683	$	3,814,355

The following table presents the weighted average haircut for Agency and non-Agency MBS as of the dates indicated:

	March 31, 2014		December 31, 2013		September 30, 2013		June 30, 2013		March 31, 2013
Agency MBS	6.9	%	6.8	%	6.7	%	6.6	%	7.3	%
Non-Agency MBS	19.8	%	20.1	%	20.0	%	19.7	%	19.1	%

The counterparties with whom we have the greatest amounts of equity at risk may vary significantly during any given period due to the short-term and generally uncommitted nature of the repurchase agreement borrowings. Equity at risk is defined as the amount pledged as collateral to the repurchase agreement counterparty in excess of the repurchase agreement amount outstanding. The following tables present the five counterparties with whom we had the greatest amounts of equity at risk as of March 31, 2014 and as of December 31, 2013:

	March 31, 2014
(amounts in thousands)	Amount Outstanding		Equity at risk
Well Fargo Bank, N.A. and affiliates (1)	$	348,399	$	97,517
JP Morgan Securities, LLC	274,519		43,858
South Street Financial Corporation	603,608		28,342
Credit Suisse Securities LLC	198,749		25,534
Bank of America Securities LLC	208,359		22,556
Remaining counterparties	1,852,049		110,865
	$	3,485,683	$	328,672

	December 31, 2013
(amounts in thousands)	Amount Outstanding		Equity at risk
Well Fargo Bank, N.A. and affiliates (1)	$	371,753	$	91,769
JP Morgan Securities, LLC	240,024		39,397
South Street Financial Corporation	601,354		29,331
Credit Suisse Securities LLC	210,861		25,093
Bank of America Securities LLC	226,768		23,886
Remaining counterparties	1,930,237		102,797
	$	3,580,997	$	312,273

(1) Amount excludes deferred costs related to our committed two-year repurchase facility with Wells Fargo Bank National which had a remaining balance of $0.1 million and $0.2 million as of March 31, 2014 and December 31, 2013, respectively.

Our repurchase agreement counterparties require us to comply with various operating and financial covenants. The financial covenants include requirements that we maintain minimum shareholders' equity (usually a set minimum, or a percentage of the highest amount of shareholders' equity since the date of the agreement), maximum decline in shareholders' equity (expressed as a percentage decline in any given period), and limits on maximum leverage (as a multiple of shareholders' equity). Operating requirements include, among other things, requirements to maintain our status as a REIT and to maintain our listing on the NYSE. Violations of one or more of these covenants could result in the lender declaring an event of default which would result in the

40

termination of the repurchase agreement and immediate acceleration of amounts due thereunder. In addition, some of the agreements contain cross default features, whereby default with one lender simultaneously causes default under agreements with other lenders.  Violations could also restrict us from paying dividends or engaging in other transactions that are necessary for us to maintain our REIT status.

We monitor and evaluate on an ongoing basis the impact these customary financial covenants may have on our operating and financing flexibility. Currently, we do not believe we are subject to any covenants that materially restrict our financing flexibility. As noted above, we have one repurchase agreement lender which requires that we maintain our enterprise level leverage as of quarter end at less than 7 times our shareholders' equity. Our overall debt was 5.9 times our shareholders' equity as of March 31, 2014.

Derivatives

Our interest rate derivative instruments require us to post initial margin at inception and variation margin based on subsequent changes in the fair value of the derivatives. The collateral posted as margin by us is typically in the form of cash or Agency MBS. Generally, as interest rates decline we will have to post collateral with the counterparty, and, as interest rates increase, the counterparty will deposit collateral with us or return our collateral (typically when the amount of collateral required to be posted exceeds a certain dollar amount). As of March 31, 2014, we had Agency MBS with a fair value of $2.6 million posted as credit support under these agreements.

Dividends

As a REIT, we are required to distribute to our shareholders amounts equal to at least 90% of our REIT taxable income for each taxable year after consideration of our tax NOL carryforwards. We generally fund our dividend distributions through our cash flows from operations. If we make dividend distributions in excess of our operating cash flows during the period, whether for purposes of meeting our REIT distribution requirements or other strategic reasons, those distributions are generally funded either through our existing cash balances or through the return of principal from our investments (either through repayment or sale). As of December 31, 2013, we had an estimated NOL carryfoward of $142.3 million. We may utilize our NOL carryforward to offset our REIT distribution requirements, subject to a limitation of $13.5 million per year.

Contractual Obligations

The following table summarizes our contractual obligations by payment due date as of March 31, 2014:

(amounts in thousands)	Payments due by period
Contractual Obligations: (1) (2)	Total		< 1 year		1-3 years		3-5 years		> 5 years
Securitization financing (3)	$	12,607	$	3,571	$	4,403	$	4,633	$	—
Operating lease obligations	1,085		119		200		206		560
Total	$	13,692	$	3,690	$	4,603	$	4,839	$	560

(1) Amounts shown exclude interest obligations as those amounts are not significant.

(2) Amounts outstanding under our repurchase agreements are excluded from the table because these amounts represent short-term financing. All amounts outstanding under our repurchase agreements as of March 31, 2014 are due within 180 days.

(3) Represents financing that is non-recourse to us as the debt is payable solely from loans and securities pledged as collateral. Payments due by period were estimated based on the principal repayments forecasted for the underlying loans and securities, substantially all of which is used to repay the associated financing outstanding.

Off-Balance Sheet Arrangements

As of March 31, 2014, we do not believe that any off-balance sheet arrangements exist that are reasonably likely to have a material effect on our current or future financial condition, results of operations, liquidity or capital resources.

RECENT ACCOUNTING PRONOUNCEMENTS

There are no recently issued accounting pronouncements which have had or are expected to have a material impact on the Company's consolidated financial statements.

41

FORWARD-LOOKING STATEMENTS

Certain written statements in this Quarterly Report on Form 10-Q that are not historical facts constitute “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the Exchange Act. Statements in this report addressing expectations, assumptions, beliefs, projections, future plans and strategies, future events, developments that we expect or anticipate will occur in the future, and future operating results are forward-looking statements. Forward-looking statements are based upon management’s beliefs, assumptions, and expectations as of the date of this report regarding future events and operating performance, taking into account all information currently available to us, and are applicable only as of the date of this report. Forward-looking statements generally can be identified by use of words such as “believe”, “expect”, “anticipate”, “estimate”, “plan” “may”, “will”, “intend”, “should”, “could” or similar expressions. We caution readers not to place undue reliance on our forward-looking statements, which are not historical facts and may be based on projections, assumptions, expectations, and anticipated events that do not materialize. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statement whether as a result of new information, future events, or otherwise.

Forward-looking statements in this Quarterly Report on Form 10-Q may include, but are not limited to:

• Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations;

• Monetary policy of the Federal Reserve;

• Our financing and hedging strategy, including our target leverage ratios, anticipated trends in financing costs, changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;

• Our investment portfolio composition and target investments;

• Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investment portfolio;

• Our liquidity and ability to access financing, and the anticipated availability and cost of financing;

• Our use of and restrictions on using our tax NOL carryfoward;

• The status of pending litigation;

• Estimates of future interest expenses related to the Company's derivative instruments;

• The status of regulatory rule-making or review processes and the status of reform efforts in the repurchase agreement financing market;

• Market, industry and economic trends; and

• Interest rates.

Forward-looking statements are inherently subject to risks, uncertainties and other factors that could cause our actual results to differ materially from historical results or from any results expressed or implied by such forward-looking statements. Not all of these risks and other factors are known to us. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. The projections, assumptions, expectations or beliefs upon which the forward-looking statements are based can also change as a result of these risks or other factors.  If such a risk or other factor materializes in future periods, our business, financial condition, liquidity and results of operations may vary materially from those expressed or implied in our forward-looking statements.

While it is not possible to identify all factors, some of the factors that may cause actual results to differ from historical results or from any results expressed or implied by forward-looking statements, or that may cause our projections, assumptions, expectations or beliefs to change, include the following:

• the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, particularly those set forth under Part II, Item 1A, “Risk Factors”;

• our ability to find suitable reinvestment opportunities;

• changes in economic conditions;

• changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;

42

• our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;

• actual or anticipated changes in Federal Reserve monetary policy;

• adverse reactions in financial markets related to the budget deficit or national debt of the United States government; potential or actual default by the United States government on Treasury securities; and potential or actual downgrades to the sovereign credit rating of the United States;

• the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;

• the cost and availability of new equity capital;

• changes in our use of leverage;

• the quality of performance of third-party servicer providers of our loans and loans underlying our securities;

• the level of defaults by borrowers on loans we have securitized;

• changes in our industry;

• increased competition;

• changes in government regulations affecting our business;

• changes in the repurchase agreement financing markets and other credit markets;

• changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;

• government initiatives to support the U.S financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including by imposing standards for originating residential mortgage loans;

• GSE reform or other government policies and actions; and

• ownership shifts under Section 382 that further limit the use of our tax NOL carryforward.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We seek to manage various risks inherent in our business strategy, which include interest rate, prepayment, reinvestment, market value, credit, and liquidity risks. These risks can and do cause fluctuations in our book value per common share and our net income and comprehensive income. We attempt to manage these risks and earn an acceptable return for our shareholders as discussed below.

Interest Rate Risk

Investing in interest-rate sensitive investments on a leveraged basis subjects us to interest rate risk primarily from the mismatch between interest-rate reset dates (or maturity) of our assets and the maturity of our liabilities. Borrowing costs on our liabilities are generally based on prevailing market rates and reset more frequently than interest rates on our assets. During a period of rising interest rates (particularly short term rates), our borrowing costs will increase faster than our asset yields, negatively impacting our net interest income. The amount of the impact will depend on the composition of portfolio and on the effectiveness of our hedge instruments at the time, as well as the magnitude and the duration of the increase in interest rates. In addition, our adjustable rate assets may have limits or caps on the amount that an interest rate may reset while our liabilities do not have rate reset caps. Changes in interest rates, particularly rapid changes, may also negatively impact the market value of our investments which reduces our book value. See "Market Value Risk" below for further discussion of the risks to the market value of our investments.

We attempt to manage our exposure to changes in interest rates by investing in instruments that have shorter maturities or interest reset dates, entering into hedging transactions (such as interest rate swaps and Eurodollar futures) and by managing our investment portfolio within interest rate risk tolerances set by our Board of Directors. Our current goal is to maintain a net portfolio duration (a measure of interest rate risk) within a range of 0.5 to 1.5 years. Our portfolio duration may drift outside of our target range at various times due to changes in market conditions, changes in actual or expected prepayment rates on our investments, changes in interest rates, changes in credit spreads, and activity in our investment portfolio. In addition, duration is driven by model inputs, and in the case of Agency RMBS, the most important inputs include anticipated prepayment speeds. Estimates of prepayment speeds can vary significantly by investor for the same security and therefore estimates of security and portfolio duration can vary significantly.

43

Effect of Changes in Interest Rates on Net Interest Income and Market Value. The table below shows the projected sensitivity of our adjusted net interest income and the projected market value of our investments and derivative instruments carried at fair value as they existed as of March 31, 2014 based on an instantaneous parallel shift in market interest rates as set forth in the table and assumes the following:

• The "percentage change in adjusted net interest income" included in the table below includes the anticipated impact of changes in expected prepayment speeds on our investments and also assumes that net proceeds received from pay downs on the portfolio are reinvested in MBS in amounts proportionate to the portfolio composition that existed as of March 31, 2014 and at yields consistent with those as of March 31, 2014 adjusted for the parallel shift in the rates below.

• The "percentage change in market value" included in the table below is based on the immediate change in market value of the investment portfolio based on the instantaneous shift in market interest rates. The projections for market value do not assume any change in credit spreads.

We are presenting only a -50 basis point parallel shift in interest rates given the low level of absolute rates at March 31, 2014. Changes in types of investments, changes in future interest rates, changes in credit spreads, changes in the shape of the yield curve, the availability of financing and/or the mix of our investments and financings including derivative instruments may cause actual results to differ significantly from the modeled results. In addition, declines in market value of our investments and derivative instruments may occur from changes in market expectations on future interest rates and/or Federal Reserve monetary policy which are not modeled in the table below. Other factors will also impact the amounts set forth below, such as whether we raise additional capital or change our investment allocations or strategies. Accordingly, amounts shown below could differ materially from actual results. There can be no assurance that assumed events used for the model below will occur, or that other events will not occur, that will affect the outcomes; therefore, the tables below and all related disclosures constitute forward-looking statements.

Parallel Shift in Interest Rates	Percentage change in adjusted net interest income (1)	Percentage change in market value (2)
+100	(19.1)%	(1.5)%
+50	(8.2)%	(0.7)%
0	—%	—%
-50	1.4%	0.5%

(1) Includes changes in interest expense from the financings for our investments as well as our derivative instruments.

(2) Includes changes in market value of our investments and derivative instruments, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet.

Management also considers changes in the shape of the interest rate curves in assessing how much interest rate risk exists in the investment portfolio. The table below shows the percentage change in projected market value of our investment portfolio net of hedges for changes in the shape of the U.S. Treasury curve (with similar changes to the interest rate swap curve and Eurodollar curves) as of March 31, 2014.

44

Basis point change in  2-year yield	Basis point change in  10-year yield	Percentage change in  projected market value
0	+25	(0.1)%
+10	+50	(0.3)%
+10	+75	(0.5)%
+25	+75	(0.6)%
+25	0	(0.2)%
+50	0	(0.4)%
-10	-50	0.2%

Our adjustable rate investments have interest rates which are predominantly based on one-year LIBOR and contain periodic (or interim) and lifetime interest rate caps which limit the amount by which the interest rate may reset on the investment. The following table presents information about the lifetime and interim interest rate caps (where interim interest rate caps include both initial adjustments of interest rates which generally are 5% as well as periodic adjustments which generally are 2%) on our adjustable-rate Agency MBS portfolio as of March 31, 2014:

Lifetime Interest Rate Caps			Interim Interest Rate Caps
	% of Total			% of Total
>7.0% to 10.0%	87.1	%	1.0%	0.1	%
>10.0% to 11.0%	9.7	%	2.0%	16.3	%
>11.0% to 12.1%	3.2	%	5.0%	83.6	%
	100.0	%		100.0	%

Market Value Risk

Market value risk generally represents the risk of loss in value of our investment securities and derivatives due to fluctuations in interest rates, prepayment rates and changes in the perceived risk in owning such financial instrument. Securities in our investment portfolio and derivative instruments are reflected at their estimated fair value on our consolidated balance sheet. Changes in the fair value of our derivative instruments are recorded within "net income" on our consolidated statement of comprehensive income while changes in the fair value of our investments are recorded within "other comprehensive income" on our consolidated statement of comprehensive income. As demonstrated in the tables above, in a rising interest rate environment, the fair value of our securities tends to decrease; conversely, in a decreasing interest rate environment, the fair value of our securities tends to increase. The fair value of our securities will also fluctuate due to changes in credit spreads (which represent the market's valuation of the perceived riskiness of assets relative to risk-free rates), changes in actual prepayments or expected prepayments, the perceived liquidity of the investment, actual or expected credit performance, and other factors. We attempt to manage market value risk by managing our exposure to these factors (although we do not actively attempt to manage market value risk from changes in credit spreads). For example, the types of derivative instruments we are currently using to hedge the interest rates on our debt tend to increase in value when our investment portfolio decreases in value, although not a one-to-one correlation. See the analysis in the “Interest Rate Risk” section above, which presents the estimated change in our portfolio value given changes in market interest rates. Regardless of whether an investment is carried in our financial statements as available for sale or as trading, we will monitor the change in its market value. In particular, we will monitor changes in the value of investments collateralizing our repurchase agreements for liquidity management and other purposes, including maintaining appropriate collateral margins.

Fluctuations in market credit spreads will vary based on the type of investments. In general, market credit spreads will have less volatility for Agency MBS than non-Agency MBS. The table below is an estimate of the projected change in our portfolio market value given the indicated change in market credit spreads as of March 31, 2014:

45

Basis Point Change in Market Credit Spreads	Percentage change in projected market value
+50	(2.1)%
+25	(1.1)%
0	—%
-25	1.1%
-50	2.2%

Prepayment and Reinvestment Risk

Prepayment risk is the risk of an early, unscheduled return of principal on an investment. We are subject to prepayment risk from premiums paid on investments which we acquire. Purchase premiums on our investments are amortized as a reduction in interest income using the effective yield method under GAAP, adjusted for the actual and anticipated prepayment activity of the investment. An increase in the actual or expected rate of prepayment will typically accelerate the amortization of purchase premiums, thereby reducing the yield/interest income earned on such assets. Principal prepayments on our investments are influenced by changes in market interest rates and a variety of economic, geographic, government policy and other factors beyond our control.

Prepayment risk results from both our RMBS and CMBS investments. The majority of the loans underlying our RMBS are ARMs or Hybrid ARMs. Prepayments on these loans accelerate in a declining interest rate environment, as the loans age, and as the loans near their respective interest rate reset dates, particularly the initial reset date. Our prepayment models anticipate acceleration of prepayments in these events. To the extent the actual prepayments exceed our modeled prepayments, or if we change our future prepayment expectations, we will record adjustments to our premium amortization which may negatively impact our net interest income and could impact the fair value of our RMBS.

As an indication of our prepayment risk on our RMBS portfolio, the following table summarizes information for our Agency RMBS portfolio regarding the net premium and weighted average coupon by months until interest rate reset ("MTR") or until maturity in the case of fixed-rate securities as of the end of the past four quarters:     

	March 31, 2014					December 31, 2013					September 30, 2013					June 30, 2013
($ in thousands)	Net Premium			WAC		Net Premium			WAC		Net Premium			WAC		Net Premium			WAC
0-12 MTR	$	37,353		3.02	%	$	42,082		2.97	%	$	35,943		2.91	%	$	35,673		3.29	%
13-24 MTR	9,210			3.64	%	11,234			3.73	%	19,583			3.80	%	23,270			3.81	%
25-60 MTR	46,756			3.50	%	46,419			3.66	%	6,894			3.66	%	7,109			3.76	%
> 60 MTR	46,591			3.00	%	54,496			2.99	%	99,961			3.00	%	104,185			3.05	%
Fixed rate	(11		)	2.51	%	(11		)	2.51	%	(11		)	2.51	%	(12		)	2.51	%
Total premium, net	$	139,899		3.20	%	$	154,220		3.22	%	$	162,370		3.26	%	$	170,225		3.34	%
Par/notional balance	$2,438,133					$2,591,568					$2,723,084					$2,966,661
Premium, net as a % of par value	5.7		%			6.0		%			6.0		%			5.7		%

Loans underlying our RMBS do not have any specific prepayment protection whereas loans underlying our CMBS and CMBS IO securities generally have some form of prepayment protection provisions (such as prepayment lock-outs) or prepayment compensation provisions (such as yield maintenance or prepayment penalties). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay; however, the amount of the prepayment penalty required to be paid may decline over time, and as loans age, interest rates decline, or market values of collateral supporting the loans increase, prepayment penalties may lessen as an economic disincentive to the borrower over time. Generally, our experience has been that prepayment lock-out and yield maintenance provisions result in stable prepayment performance from period to period. There are no prepayment protections, however, if the loan defaults and the loan is partially or wholly repaid

46

earlier as a result of loss mitigation actions taken by the underlying loan servicer. Historically, our default experience on loans in CMBS and CMBS IO has been relatively low.

Without these prepayment protection provisions, prepayment risk on CMBS IO would be particularly acute as these investments have no principal balance (interest payments are based on the notional amount of the underlying commercial loans) and therefore are all premium. Prepayment protection and compensation provisions generally, but not always, differ by the type of GSE issuing the MBS. The majority of our Agency CMBS IO are issued by Freddie Mac which generally have initial prepayment lock-outs followed by a defeasance period which generally extends to within six months of the stated maturities of the underlying loans. The following table details our Agency CMBS IO portfolio by GSE as of the end of the past four quarters:

(amounts in thousands)	March 31, 2014		December 31, 2013		September 30, 2013		June 30, 2013
Fannie Mae	$	68,587	$	70,288	$	73,214	$	78,630
Freddie Mac	325,447		312,089		309,147		311,496
Ginnie Mae	77,211		77,950		93,247		160,063
	$	471,245	$	460,327	$	475,608	$	550,189

We seek to manage our prepayment risk on our MBS by diversifying our investments, seeking investments which we believe will have superior prepayment performance, and investing in securities which have some sort of prepayment prohibition or yield maintenance (as is the case with CMBS and CMBS IO). With respect to RMBS, we will seek to invest in RMBS where we believe the underlying loans have favorable prepayment characteristics such as lower loan balances or favorable origination, borrower or geographic characteristics.

We are also subject to reinvestment risk as a result of the prepayment, repayment and sales of our investments. Yields on assets in which we invest now are generally lower than yields on existing assets that we may sell or which may be repaid, due to lower overall interest rates and more competition for these as investment assets. As a result, our interest income may decline in the future, thereby reducing earnings per share. In order to maintain our investment portfolio size and our earnings, we need to reinvest our capital into new interest-earning assets. If we are unable to find suitable reinvestment opportunities, interest income on our investment portfolio and investment cash flows could be negatively impacted.

Credit Risk

Credit risk is the risk that we will not receive all contractual amounts due on investments that we own due to default by the borrower or due to a deficiency in proceeds from the liquidation of the collateral securing the obligation. We are also exposed to credit risk on investments that we own at a premium. For investments owned at premiums, defaults on the underlying loan typically result in the complete loss of any remaining unamortized premium we paid.

We attempt to mitigate our credit risk by purchasing Agency MBS and higher quality non-Agency MBS. Agency MBS have credit risk to the extent that Fannie Mae or Freddie Mac fails to remit payments on the MBS for which they have issued a guaranty of payment. Given the improved financial performance and conservatorship of these entities and the continued support of the U.S. government, we believe this risk is low. For our non-Agency MBS, we will generally only purchase investment grade securities (rated 'BBB' or better by a least one of the nationally recognized statistical ratings organizations).

Almost all of our non-Agency securities are CMBS and CMBS IO. Of the $376.0 million in non-Agency CMBS as of March 31, 2014, approximately $264.0 million is invested in mezzanine tranches on multifamily securities issued by Freddie Mac. The credit characteristics of these securities are considered favorable by management because the performance of the underlying loans has been very good in large part due to the strict underwriting requirements of this program. For our Non-Agency CMBS IOs, which consist entirely of premium, we seek to invest in securities where we are comfortable with the credit profile of the loans underlying the security.

The following table presents information on our non-Agency MBS by credit rating as of March 31, 2014:

47

	March 31, 2014
(amounts in thousands)	CMBS		CMBS IOs		RMBS		Weighted average
AAA	$	—	$	210,184	$	—	34.9	%
AA	75,990		1,343		—		12.8	%
A (1)	251,959		—		—		41.8	%
Below A or not rated (1)	48,047		—		15,570		10.5	%
	$	375,996	$	211,527	$	15,570	100.0	%

(1) Certain of our non-Agency MBS were purchased at modest discounts to their par value. The discounts resulted from the MBS having coupon interest rates that were less than the prevailing market rates for similar securities when they were purchased, and not from anticipated credit losses on the collateral. We believe the underlying collateral value currently, and at the time of purchase, is adequate to prevent any credit losses on the respective MBS.

With respect to our securitized mortgage loans, these loans are well-seasoned, thereby lowering our average loan-to-value (“LTV”) ratio and decreasing our risk of loss. Other efforts to mitigate credit risk include maintaining a risk management function that monitors and oversees the performance of the servicers of the mortgage loans as well as providing an allowance for loan loss as required by GAAP.

Liquidity Risk

We have liquidity risk principally from the use of recourse repurchase agreements to finance our ownership of securities. In general, our repurchase agreements provide a source of uncommitted short-term financing that finances a longer-term asset, thereby creating a mismatch between the maturity of the asset and of the associated financing. Our repurchase agreements are renewable at the discretion of our lenders and do not contain guaranteed roll-over terms. If we fail to repay the lender at maturity, the lender has the right to immediately sell the collateral and pursue us for any shortfall if the sales proceeds are inadequate to cover the repurchase agreement financing. In addition, repurchase agreements are collateral based and declines in the market value of our investments subject us to liquidity risk.

For further information, including how we attempt to mitigate liquidity risk and our liquidity position, please refer to “Liquidity and Capital Resources” in Part I, Item 2 of this Quarterly Report on Form 10-Q.

48

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures.

Our management evaluated, with the participation of our Principal Executive Officer and Principal Financial Officer, the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2014 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in internal control over financial reporting.

Our management is also responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rule 13a-15(f). There were no changes in our internal control over financial reporting during the three months ended March 31, 2014 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

49

PART II.

ITEM 1. LEGAL PROCEEDINGS

The Company and its subsidiaries are parties to various legal proceedings.  Although the ultimate outcome of those legal proceedings cannot be ascertained at this time, and the results of legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of those proceedings will not have a material adverse effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of the proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved. There have been no material changes during the three months ended March 31, 2014 for the legal proceedings discussed in the Annual Report on Form 10-K for the year ended December 31, 2013.

ITEM 1A.    RISK FACTORS

Risks and uncertainties identified in our Forward-Looking Statements contained in this Quarterly Report on Form 10-Q together with those previously disclosed in the Annual Report on Form 10-K for the year ended December 31, 2013 or those that are presently unforeseen could result in significant adverse effects on our financial condition, results of operations and cash flows.  See “Forward-Looking Statements” contained in Part 1, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within this Quarterly Report on Form 10-Q as well as Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013.

ITEM 2.    UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The Company has been authorized by its Board of Directors to repurchase up to $50 million of its outstanding shares of common stock through December 31, 2014. Subject to applicable securities laws and the terms of the Series A Preferred Stock designation and the Series B Preferred Stock designation, both of which are contained in our Articles of Incorporation, future repurchases of common stock will be made at times and in amounts as the Company deems appropriate, provided that the repurchase price per share is less than the Company's estimate of the current net book value of a share of common stock. Repurchases may be suspended or discontinued at any time.

The following table summarizes repurchases of our common stock that occurred during the three months ended March 31, 2014:

	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
					($ in thousands)
January 1, 2014 - January 31, 2014	—	$	—	—	$	42,145
February 1, 2014 - February 28, 2014	23,864	8.14		—	42,145
March 1 - March 31, 2014	35,286	8.81		—	42,145
Total	59,150	$	8.54	—	$	42,145

(1) These shares were withheld from certain employees to satisfy tax withholding obligations arising upon the vesting of restricted shares. Accordingly, these shares are not included in the calculation of approximate dollar value of shares that may yet be purchased under the $50 million repurchase plan authorized by the Company's Board of Directors..

50

ITEM 3.    DEFAULTS UPON SENIOR SECURITES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

None.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

Exhibit No.	Description
3.1	Restated Articles of Incorporation, effective July 9, 2008 (incorporated herein by reference to Exhibit 3.1 to Dynex’s Current Report on Form 8-K filed July 11, 2008).
3.1.1	Articles of Amendment to the Restated Articles of Incorporation, effective July 30, 2012 (incorporated herein by reference to Exhibit 3.1.1 to Dynex's Registration Statement on Form 8-A filed August 1, 2012).
3.1.2	Articles of Amendment to the Restated Articles of Incorporation, effective April 15, 2013 (incorporated herein by reference to Exhibit 3.1 to Dynex’s Current Report on Form 8-K filed April 16, 2013).
3.1.3	Articles of Amendment to the Restated Articles of Incorporation, effective June 11, 2013 (incorporated herein by reference to Exhibit 3.1.3 to Dynex's Quarterly Report on Form 10-Q filed August 9, 2013).
3.2	Amended and Restated Bylaws, amended as of December 12, 2013 (incorporated herein by reference to Exhibit 3.2 to Dynex's Annual Report on Form 10-K filed March 4, 2014).
10.17	Base salaries for executive officers of Dynex Capital, Inc. (Corrected) (filed herewith)
31.1	Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2	Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1	Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101	The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2014, formatted in XBRL (Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (unaudited), (ii) Consolidated Statements of Comprehensive Income (unaudited), (iii) Consolidated Statements of Shareholders' Equity (unaudited), (iv) Consolidated Statements of Cash Flows (unaudited), and (v) Notes to the Unaudited Consolidated Financial Statements.

51

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		DYNEX CAPITAL, INC.
Date:	August 20, 2014	/s/ Byron L. Boston
		Byron L. Boston
		Chief Executive Officer, President,
		Co-Chief Investment Officer, and Director
		(Principal Executive Officer)
Date:	August 20, 2014	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Executive Vice President, Chief Operating Officer and Chief Financial Officer
		(Principal Financial Officer)

52

EX-10.17

Exhibit 10.17

Dynex Capital, Inc.

2014 Base Salaries for Executive Officers

(Corrected)

The 2014 base salaries for Dynex Capital, Inc.’s executive officers are as follows: Thomas B. Akin, Executive Chairman -$500,000; Byron L. Boston, Chief Executive Officer, President and Co-Chief Investment Officer-$675,000; Stephen J. Benedetti, Executive Vice President, Chief Operating Officer and Chief Financial Officer-$375,000; and Smriti L. Popenoe, Executive Vice President and Co-Chief Investment Officer-$408,000.

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Byron L. Boston, certify that:

1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 20, 2014
		/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Stephen J. Benedetti, certify that:

1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	August 20, 2014
		/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 906

In connection with the Amendment No. 1 to Quarterly Report on Form 10-Q/A of Dynex Capital, Inc. (the “Company”) for the fiscal quarter ended March 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, as the Principal Executive Officer of the Company and the Principal Financial Officer of the Company, respectively, certify, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	August 20, 2014	/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer
Date:	August 20, 2014	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

XML

Fair Value of Financial Instruments Recorded basis and Fair Value (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	$ 12,064	$ 18,488
Derivative Liabilities, Fair Value Disclosure	11,137	6,681
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities, Fair Value Disclosure	3,959,852	4,018,161
Mortgage loans held for investment, net, Fair Value Disclosure	53,804	55,423
Derivative assets	12,064	18,488
Repurchase Agreements, Fair Value Disclosure	3,485,544	3,580,754
Non-recourse collateralized financing, Fair Value Disclosure	12,394	12,914
Derivative Liabilities, Fair Value Disclosure	11,137	6,681
Estimate of Fair Value, Fair Value Disclosure [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities, Fair Value Disclosure	3,959,852	4,018,161
Mortgage loans held for investment, net, Fair Value Disclosure	45,188	46,383
Derivative assets	12,064	18,488
Repurchase Agreements, Fair Value Disclosure	3,485,683	3,580,997
Non-recourse collateralized financing, Fair Value Disclosure	11,915	12,414
Derivative Liabilities, Fair Value Disclosure	$ 11,137	$ 6,681

XML

Derivatives Derivative Effect on Accumulated Other Comprehensive Income (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Derivative [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	$ 7,077,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net		4,103
Dedesignated cash flow hedge amortization	0
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	$ 5,525,000

XML

Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2014

Equity [Abstract]

Schedule of Common Stock Outstanding Roll Forward [Table Text Block]

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

	Three Months Ended
	March 31,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	3,938		298,304
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	442,035		139,600
Common stock forfeited for tax withholding on share-based compensation	(59,150	)	(52,385	)
Balance as of end of period	54,697,307		54,835,420

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2014		2013
Restricted stock outstanding as of beginning of period	520,969		448,283
Restricted stock granted	428,363		139,600
Restricted stock vested	(188,620	)	(153,720	)
Restricted stock outstanding as of end of period	760,712		434,163

XML

Fair Value of Financial Instruments Significant Unobservable Inputs Level 3 (Details) (Fair Value, Measurements, Recurring [Member], Fair Value, Inputs, Level 3 [Member])	3 Months Ended
	Mar. 31, 2014
Commercial Mortgage Backed Securities [Member]
Fair Value Inputs, Quantitative Information [Abstract]
Fair Value Inputs, Prepayment Rate	0.00%
Fair Value Inputs, Probability of Default	0.00%
Fair Value Inputs, Loss Severity	0.00%
Fair Value Inputs, Discount Rate	0.00%
Residential Mortgage Backed Securities [Member]
Fair Value Inputs, Quantitative Information [Abstract]
Fair Value Inputs, Prepayment Rate	0.00%
Fair Value Inputs, Probability of Default	0.00%
Fair Value Inputs, Loss Severity	0.00%
Fair Value Inputs, Discount Rate	0.00%

XML

Mortgage Backed Securities Mortgage backed securities (Notes)

3 Months Ended

Mar. 31, 2014

Investments, Debt and Equity Securities [Abstract]

Mortgage-backed securities

MORTGAGE-BACKED SECURITIES

The following table presents the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of March 31, 2014 and December 31, 2013:

	March 31, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,438,133	$	139,899		$	2,578,032	$	6,708	$	(45,438	)	$	2,539,302	3.20	%
CMBS	286,931		19,838			306,769		11,384		(509		)	317,644		5.23	%
CMBS IO (1)	—		461,523			461,523		11,581		(1,859		)	471,245		0.94	%
Total Agency AFS:	2,725,064		621,260			3,346,324		29,673		(47,806		)	3,328,191
Non-Agency:
RMBS	15,454		(7		)	15,447		209		(86		)	15,570		4.42	%
CMBS	375,209		(17,819		)	357,390		19,448		(842		)	375,996		5.05	%
CMBS IO (1)	—		209,301			209,301		3,374		(1,148		)	211,527		0.80	%
Total non-Agency AFS:	390,663		191,475			582,138		23,031		(2,076		)	603,093
Total AFS securities	$	3,115,727	$	812,735		$	3,928,462	$	52,704	$	(49,882	)	$	3,931,284

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $10,582,484 and $5,053,884, respectively, as of March 31, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (1)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (1)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

The Company has investments in additional Agency CMBS not included in the tables above that are designated as trading securities by the Company with fair values of $28,568 and $28,717 as of March 31, 2014 and December 31, 2013, respectively. Changes in the fair value of these Agency CMBS are recognized each reporting period within "fair value adjustments, net" as a component of the Company's net income. As of March 31, 2014 and December 31, 2013, the amortized cost of these Agency CMBS designated as trading securities was $26,786 and $26,920, respectively. The Company recognized a net unrealized loss for the three months ended March 31, 2014 of $(17) compared to a net unrealized loss of $(107) for the three months ended March 31, 2013, respectively, related to changes in fair value of these Agency CMBS designated as trading securities.

The following table presents certain information for those Agency MBS in an unrealized loss position as of March 31, 2014 and December 31, 2013:

	March 31, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	1,563,078	$	(29,207	)	120	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	126,578		(1,990		)	23	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	767,744	$	(18,600	)	80	$	670,402	$	(20,433	)	67
Non-Agency MBS	1,676		(86		)	5	6,310		(155		)	6

Because the principal and interest related to Agency MBS are guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac who have the implicit guarantee of the U.S. government, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s current leverage and anticipated liquidity.  Based on this analysis, the Company has determined that the unrealized losses on its Agency MBS as of March 31, 2014 and December 31, 2013 were temporary.

The Company also reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of these non-Agency MBS and the seasoning of the mortgage loans collateralizing these securities as well as the estimated future cash flows which include projected losses. The Company performed this evaluation for the non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of March 31, 2014 or December 31, 2013.

XML

Repurchase Agreements (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
REPURCHASE AGREEMENTS [Abstract]
Repurchase Agreements, Maturities	P93D	P114D
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	$ 3,485,544		$ 3,580,754
Repurchage agreement, Weighted Average Interest Rate	0.59%		0.61%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	3,814,355		3,890,066
Deferred Costs	(139)		(243)
Bonds [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	16,692		20,651
Repurchage agreement, Weighted Average Interest Rate	1.52%		1.59%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	18,607		19,686
Residential Mortgage Backed Securities [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	2,350,781		2,522,503
Repurchage agreement, Weighted Average Interest Rate	0.39%		0.42%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	2,421,202		2,598,158
Residential Mortgage Backed Securities [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	11,905		10,569
Repurchage agreement, Weighted Average Interest Rate	1.77%		1.80%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	14,691		12,746
Commercial Mortgage Backed Securities [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	265,475		246,849
Repurchage agreement, Weighted Average Interest Rate	0.37%		0.39%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	330,182		306,318
Commercial Mortgage Backed Securities [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	309,398		303,674
Repurchage agreement, Weighted Average Interest Rate	1.22%		1.27%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	371,273		367,859
CMBS IO [Member] | Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	382,327		369,948
Repurchage agreement, Weighted Average Interest Rate	1.14%		1.16%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	471,173		449,072
CMBS IO [Member] | Non-Agency MBS [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase agreement, balance	149,105		106,803
Repurchage agreement, Weighted Average Interest Rate	1.23%		1.27%
Pledged Financial Instruments, Not Separately Reported, Mortgage-Related Securities Available-for-sale or Held-for-investment	$ 187,227		$ 136,227

XML

Mortgage Backed Securities Mortgage backed securities designated as Trading (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Schedule of Trading Securities and Other Trading Assets [Line Items]
Trading MBS, Fair Value	$ 28,568		$ 28,717
Trading MBS, Amortized cost	26,786		26,920
Unrealized Loss on Trading Securities	$ (17)	$ (107)

XML

Repurchase Agreements Repurchase Agreements By Maturity Period (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Deferred Costs	$ 139	$ 243
Maturity up to 30 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	369,542	206,112
Maturity 31 to 60 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	715,516	492,145
Matuity 61 to 90 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	987,579	665,020
Maturity 91 to 120 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	545,628	783,371
Maturity 121 to 190 days [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	867,418	1,434,349
Repurchase Agreements [Member]
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Repurchase Agreements, Maturities	$ 3,485,683	$ 3,580,997

XML

Repurchase Agreements Counterparty Information (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014 Agreements
Counterparty Information [Line Items]
Equity at Risk	$ 97,517
Amount outstanding with counterparty	348,399
Weighted average interest rate, amount outstanding with counterparty	1.27%
Line of Credit Facility, Amount Outstanding	165,693
Line of Credit Facility, Maximum Borrowing Capacity	$ 250,000
Line of Credit Facility, Interest Rate at Period End	1.42%
Number of Counterparties with Borrowings Outstanding	21
Available Repurchase Agreement Counterparties	31

XML

Net Income Per Common Share

3 Months Ended

Mar. 31, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Net Income per Common Share

NET (LOSS) INCOME PER COMMON SHARE

Net (loss) income per common share is presented on both a basic and diluted basis.  Because the Company's Series A Cumulative Redeemable Preferred Stock and Series B Cumulative Redeemable Preferred Stock are redeemable at the Company's option for cash only, and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares is excluded from the calculation of diluted net (loss) income per common share. For the three months ended March 31, 2013, diluted net income per common share assumes the exercise of stock options outstanding during the period using the treasury stock method. The Company did not have any stock options outstanding for the three months ended March 31, 2014. Holders of unvested shares of our issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC 260-10 and therefore are included in the computation of basic net (loss) income per share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted is converted to one equal share of common stock.

The following table presents the calculation of the numerator and denominator for both basic and diluted net (loss) income per common share for the periods indicated:

	For the Three Months Ended
	March 31, 2014						March 31, 2013
	Net  Income			Weighted-Average Common Shares			Net  Income			Weighted- Average Common Shares
Net (loss) income	$	(734	)				$	19,603
Preferred stock dividends	(2,294		)				(1,222		)
Net (loss) income to common shareholders	(3,028		)	54,625,601			18,381			54,300,020
Effect of dilutive stock options	—			—			—			754
Diluted net (loss) income to common shareholders	$	(3,028	)	54,625,601			$	18,381		54,300,774
Net (loss) income per common share:
Basic				$	(0.06	)				$	0.34
Diluted (1)				$	(0.06	)				$	0.34

(1) The Company did not have any anti-dilutive securities outstanding during the three months ended March 31, 2014 or March 31, 2013.

XML

Derivatives (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	$ 11,137		$ 6,681
Derivative assets	12,064		18,488
Derivative Liabilities	(11,137)		(6,681)
Description of Derivative Activity Volume	The following table summarizes activity related to derivative instruments for the periods indicated:(amounts in thousands)Interest Rate Swaps Eurodollar FuturesNotional amount as of December 31, 2013$790,000 $9,000,000Additions75,000 —Settlements, terminations, or expirations(15,000) —Notional amount as of March 31, 2014(1)$850,000 $9,000,000(1)The Eurodollar futures notional amount as of March 31, 2014 represents the total notional of the 3-month contracts with expiration dates from 2016 to 2020. The maximum notional outstanding for any future 3-month period does not exceed $1,175,000.
Loss on derivative instruments, net	(13,422)	(17)
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative assets	12,064		18,488
Derivative Asset, Notional Amount	525,000		575,000
Derivative Liabilities	(11,137)		(6,681)
Derivative Liability, Notional Amount	9,325,000		9,215,000
Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount			790,000
Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net	(9,008)	(17)
Weighted-average Fixed Rate Swapped	1.61%
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	(1,378)		(1,336)
Derivative Liability, Notional Amount	325,000		215,000
Derivative, Notional Amount	850,000
Eurodollar Future [Member]
Derivative [Line Items]
Derivative, Notional Amount			9,000,000
Notional Amount of Derivative Instruments Added	0
Notional Amount of Derivative Instruments Terminated	0
Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net	(4,414)	0
Eurodollar Future [Member] | Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	(9,759)		(5,345)
Derivative Liability, Notional Amount	9,000,000		9,000,000
Derivative, Notional Amount	9,000,000
Interest Rate Swap Agreements, Maturities in Next 37-48 Months [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	185,000
Weighted-average Fixed Rate Swapped	0.92%
Interest Rate Swap Agreements, Maturities in Next 49-60 Months [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	350,000
Weighted-average Fixed Rate Swapped	1.62%
Interest Rate Swap Agreements, Maturities in Next 61-72 Months [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	35,000
Weighted-average Fixed Rate Swapped	1.24%
Interest Rate Swap Agreements, Maturities in Next 73-84 Months [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	100,000
Weighted-average Fixed Rate Swapped	2.08%
Interest Rate Swap Agreements, Maturities in Next 109-127 Months [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	180,000
Weighted-average Fixed Rate Swapped	2.13%
Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Derivative Instruments Added	75,000
Notional Amount of Derivative Instruments Terminated	$ 15,000

XML

Shareholders' Equity (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended						3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014 At the market progam [Member]	Mar. 31, 2013 At the market progam [Member]	Mar. 31, 2014 Series A Preferred Stock [Member]	Dec. 31, 2013 Series A Preferred Stock [Member]	Mar. 31, 2014 Series B Preferred Stock [Member]	Dec. 31, 2013 Series B Preferred Stock [Member]	Mar. 31, 2014 Common Stock [Member] At the market progam [Member]	Mar. 31, 2014 Restricted Stock [Member]	Mar. 31, 2014 Four to five years [Member] Restricted Stock [Member]
Class of Stock [Line Items]
Nonvested restricted stock, fair value remaining to be amortized										$ 6,092	$ 541
Preferred Stock, Dividend Rate, Percentage					8.50%		7.625%
Preferred Stock, Liquidation Preference Per Share	$ 25.00
Preferred Stock, Shares Issued					2,300,000	2,300,000	2,250,000	2,250,000
Shareholders' Equity, Common Stock [Roll Forward]
Balance at beginning of period	54,310,484	54,268,915
Common stock issued under DRIP	3,938	298,304
Common stock issued under ATM program			0	180,986
Common stock issued or redeemed under Stock and Incentive Plans	442,035	139,600
Common stock forfeited for tax withholding on share-based compensation	(59,150)	(52,385)
Balance at end of period	54,697,307	54,835,420
ATM program, authorized shares remaining									7,416,520
Dividend reinvestment plan, shares authorized	3,000,000
Dividends declared per common share	$ 0.25
Stock Repurchase Program, Authorized Amount	50,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 42,145
Stock issued during period, remaining shares available, dividend reinvestment plan	2,462,960

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
ASSETS
Mortgage-backed securities	$ 3,959,852	$ 4,018,161
Mortgage loans held for investment	53,804	55,423
Cash and cash equivalents	61,168	69,330
Restricted cash	18,242	13,385
Derivative assets	12,064	18,488
Principal receivable on investments	8,112	12,999
Accrued interest receivable	23,387	21,703
Other assets, net	7,653	7,648
Total assets	4,144,282	4,217,137
Liabilities:
Repurchase agreements	3,485,544	3,580,754
Payable for unsettled mortgage-backed securities	16,086	10,358
Non recourse collateralized financing	12,394	12,914
Derivative Liabilities	11,137	6,681
Accrued interest payable	2,846	2,548
Accrued dividends payable	15,612	16,601
Other liabilities	1,648	1,405
Total liabilities	3,545,267	3,631,261
Shareholders’ equity:
Common stock, par value $.01 per share, 200,000,000 shares authorized; 54,697,307 and 54,310,484 shares issued and outstanding, respectively	547	543
Additional paid-in capital	761,827	761,550
Accumulated other comprehensive income	(4,256)	(33,816)
Accumulated deficit	(268,761)	(252,059)
Total shareholders' equity	599,015	585,876
Total liabilities and shareholders’ equity	4,144,282	4,217,137
Series A Preferred Stock [Member]
Shareholders’ equity:
Preferred Stock, par value $.01 per share	55,407	55,407
Series B Preferred Stock [Member]
Shareholders’ equity:
Preferred Stock, par value $.01 per share	$ 54,251	$ 54,251

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating activities:
Net (loss) income	$ (734)	$ 19,603
Adjustments to reconcile net income to cash provided by operating activities:
Decrease (increase) in accrued interest receivable	1,684	1,401
(Decrease) increase in accrued interest payable	298	(22)
Provision for loan losses	0	261
Loss on derivative instruments, net	(13,422)	(17)
Loss (gain) on sale of investments, net	(3,307)	1,391
Fair value adjustments, net	32	(140)
Amortization and depreciation	34,829	32,117
Stock-based compensation expense	672	481
Other operating activities	175	4,400
Net cash and cash equivalents provided by operating activities	49,903	45,405
Investing activities:
Purchase of investments	127,552	438,376
Principal payments received on investments	128,676	215,751
Proceeds from sales of investments	59,799	31,158
Principal payments received on mortgage loans held for investment, net	1,605	5,737
Net payments on derivatives not designated as hedges	2,542	174
Other investing activities	5	827
Net cash and cash equivalents used in investing activities	59,981	(186,731)
Financing activities:
(Repayments of) borrowings under repurchase agreements, net	(95,314)	144,023
Principal payments on non-recourse collateralized financing	(527)	(2,024)
Increase in restricted cash	4,857	0
Proceeds from issuance of common stock	114	5,152
Payments Related to tax withholding for share-based compensation	505	545
Dividends paid	16,957	16,960
Net cash and cash equivalents provided by (used in) financing activities	(118,046)	129,646
Net increase (decrease) in cash and cash equivalents	(8,162)	(11,680)
Cash and cash equivalents at beginning of period	69,330	55,809
Cash and cash equivalents at end of period	61,168	44,129
Supplemental Disclosure of Cash Activities:
Cash paid for interest	$ 4,935	$ 10,381

XML

Offsetting Assets and Liabilities Offsettting Liabilities (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Offsetting Liabilities [Line Items]
Derivative Liability, Fair Value, Gross Liability	$ 11,137	$ 6,681
Derivative Liability, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	11,137	6,681
Derivative, Collateral, Right to Reclaim Securities	(1,340)	(1,299)
Derivative, Collateral, Right to Reclaim Cash	(9,797)	(5,382)
Derivative Liability, Fair Value, Amount Offset Against Collateral	0	0
Securities Sold under Agreements to Repurchase, Gross	3,485,544	3,580,754
Securities Sold under Agreements to Repurchase, Asset	0	0
Repurchase agreements	3,485,544	3,580,754
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Securities	(3,485,544)	(3,580,754)
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash	0	0
Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral	0	0
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Gross	3,496,681	3,587,435
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Asset	0	0
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned	3,496,681	3,587,435
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities	(3,486,884)	(3,582,053)
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Cash	(9,797)	(5,382)
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Amount Offset Against Collateral	$ 0	$ 0

XML

Offsetting Assets and Liabilities Offsetting Assets (Tables)

3 Months Ended

Mar. 31, 2014

Offsetting Assets [Line Items]

Offsetting Assets [Table Text Block]

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Received as Collateral			Cash Received as Collateral
March 31, 2014
Derivative assets	$	12,064	$	—	$	12,064	$	(395	)	$	(7,954	)	$	3,715
December 31, 2013:
Derivative assets	$	18,488	$	—	$	18,488	$	(193	)	$	(12,141	)	$	6,154

XML

Fair Value of Financial Instruments Fair Value on a Recurring Basis (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	$ 3,959,852	$ 4,018,161
Derivative assets	12,064	18,488
Derivative Liabilities	11,137	6,681
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	3,959,852	4,018,161
Other Investments, Fair Value Disclosure		18,488
Derivative assets	12,064
Total assets carried at fair value	3,971,916	4,036,649
Derivative Liabilities	11,137	6,681
Total liabilities carried at fair value	11,137	6,681
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	0	0
Other Investments, Fair Value Disclosure		0
Derivative assets	0
Total assets carried at fair value	0	0
Derivative Liabilities	9,759	5,345
Total liabilities carried at fair value	9,759	5,345
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	3,893,465	3,944,681
Other Investments, Fair Value Disclosure		18,488
Derivative assets	12,064
Total assets carried at fair value	3,905,529	3,963,169
Derivative Liabilities	1,378	1,336
Total liabilities carried at fair value	1,378	1,336
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	66,387	73,480
Other Investments, Fair Value Disclosure		0
Derivative assets	0
Total assets carried at fair value	66,387	73,480
Derivative Liabilities	0	0
Total liabilities carried at fair value	$ 0	$ 0

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2014

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

	March 31, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,959,852	$	—	$	3,893,465	$	66,387
Derivative assets	12,064		—		12,064		—
Total assets carried at fair value	$	3,971,916	$	—	$	3,905,529	$	66,387
Liabilities:
Derivative liabilities	$	11,137	$	9,759	$	1,378	$	—
Total liabilities carried at fair value	$	11,137	$	9,759	$	1,378	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

Fair Value Inputs, Assets, Quantitative Information [Table Text Block]

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of March 31, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.5	%	35.0	%	8.8	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.8	%

(1) Data presented are weighted averages.

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents the activity of the instruments fair valued at Level 3 during the three months ended March 31, 2014:

	Three Months
	March 31, 2014
	Level 3 Fair Values
	Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of December 31, 2013	$	70,733		$	2,747		$	73,480
Change in fair value included in OCI	27			(126		)	(99		)
Principal payments	(6,993		)	(395		)	(7,388		)
Accretion	65			329			394
Balance as of March 31, 2014	$	63,832		$	2,555		$	66,387

Recorded basis and fair value [Table Text Block]

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,959,852	$	3,959,852	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	53,804		45,188		55,423		46,383
Derivative assets	12,064		12,064		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,485,544	$	3,485,683	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	12,394		11,915		12,914		12,414
Derivative liabilities	11,137		11,137		6,681		6,681

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Organization and Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation

The accompanying consolidated financial statements of Dynex Capital, Inc. and its qualified real estate investment trust (“REIT”) subsidiaries and its taxable REIT subsidiary (together, “Dynex” or the “Company”) have been prepared in accordance with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. The financial information included herein is unaudited; however, in the opinion of management, all significant adjustments, consisting of normal recurring accruals considered necessary for a fair presentation of the consolidated financial statements, have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statement of income for the three months ended March 31, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statement of comprehensive income for the three months ended March 31, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation

The consolidated financial statements include the accounts of the Company, its qualified REIT subsidiaries and its taxable REIT subsidiary. The consolidated financial statements represent the Company’s accounts after the elimination of intercompany balances and transactions. The Company consolidates entities in which it owns more than 50% of the voting equity and control does not rest with others and variable interest entities in which it is determined to be the primary beneficiary in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 810-10. The Company follows the equity method of accounting for investments in which it owns greater than a 20% and less than 50% interest in partnerships and corporate joint ventures or when it is able to influence the financial and operating policies of the investee but owns less than 50% of the voting equity. The Company did not have any investments in which it owned less than a 50% interest in the voting equity as of March 31, 2014 or December 31, 2013.

In accordance with ASC Topic 810-10, the Company also consolidates certain trusts through which it has securitized mortgage loans held for investment. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period.  Actual results could differ from those estimates.  The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, allowance for loan losses, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

Federal Income Taxes

The Company believes it has complied with the requirements for qualification as a REIT under the Internal Revenue Code of 1986, as amended (the "Code").  As such, the Company believes that it qualifies as a REIT for federal income tax purposes, and it generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.  The Company uses the calendar year for both tax and financial reporting purposes.  There may be differences between taxable income and income computed in accordance with GAAP.

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated the majority of its investments in MBS as available-for-sale ("AFS"), and the remainder is designated as trading. All of the Company’s MBS are recorded at their fair value on its consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until the security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may, from time to time, sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method. Changes in the fair value of MBS designated as trading are recognized in net income within "fair value adjustments, net". Gains and losses realized upon the sale, impairment, or other disposal of a trading security are also recognized within "fair value adjustments, net".

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated AA and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual prepayment activity as well as changes in projected future cash flows in accordance with ASC Topic 310-20. The Company's projections of future cash flows are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company has purchased non-Agency MBS rated less than 'AA' by at least one national rating agency at discounts to their par value, and management does not believe these discounts to be substantial. The Company records the discount accretion into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

The accrual of interest on MBS is discontinued when, in the opinion of management, it is probable that all amounts contractually due will not be collected, and in certain instances, as a result of an other-than-temporary impairment analysis (see discussion below). All interest accrued but not collected for investments that are placed on a non-accrual status or are charged-off is reversed against interest income. Interest on these investments is accounted for on the cash-basis or cost-recovery method until the affected investment or investments qualify for return to accrual status. Investments are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured.

Determination of MBS Fair Value.In accordance with ASC Topic 820, the Company determines the fair value for the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. The Company's application of ASC Topic 820 guidance is discussed further in Note 7.

Other-than-Temporary Impairment.The Company evaluates all MBS in its investment portfolio for other-than-temporary impairments ("OTTI") by comparing the amortized cost of each security in an unrealized loss position against the present value of expected future cash flows of the security. If there has been a significant adverse change in the cash flow expectations for a security resulting in its amortized cost becoming greater than the present value of its expected future cash flows, an other-than-temporary credit impairment has occurred. If the Company does not intend to sell and is not more likely than not required to sell the security, the credit loss is recognized in earnings and the balance of the unrealized loss is recognized in other comprehensive income (loss). If the Company intends to sell the security or will be more likely than not required to sell the security, the full unrealized loss is recognized in earnings.

In periods after the recognition of an OTTI loss for MBS, the Company accounts for the other-than-temporarily impaired MBS as if the debt security had been purchased on the measurement date of the OTTI at an amortized cost basis equal to the previous amortized cost basis less the OTTI recognized in earnings. For MBS for which OTTIs were recognized in earnings, the difference between the new amortized cost basis and the cash flows expected to be collected shall be accreted into interest income using the effective interest method. The Company continues to estimate the present value of cash flows expected to be collected over the life of the MBS. If upon subsequent evaluation, there is an increase in the cash flows expected to be collected or if actual cash flows are greater than cash flows previously expected, such changes will be accounted for as a prospective adjustment to the accretable yield in accordance with ASC Topic 310-30 even if the MBS would not otherwise be within the scope of that guidance. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment consist primarily of securitized mortgage loans reported at amortized cost in accordance with ASC Topic 310-10. Securitized mortgage loans are pledged to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as a portion of "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. Less than 2% of the Company's mortgage loans held for investment are unsecuritized; these loans are also reported at amortized cost. In accordance with ASC Topic 310-10, an allowance has been established for currently existing and probable losses on all of the Company's mortgage loans held for investment.

Repurchase Agreements

Repurchase agreements are treated as financings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments

The Company accounts for its derivative instruments in accordance with ASC Topic 815. ASC Topic 815 requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "loss on derivative instruments, net".

The Company has Eurodollar futures, which are valued based on closing exchange prices. Variation margin is exchanged daily to settle any changes in the value of the Eurodollar futures. Gains and losses associated with purchases and short sales of futures contracts are reported in "loss on derivative instruments, net" on our consolidated statement of comprehensive income.

The Company has elected to use the portfolio exception in ASC 820-10-35-18D with respect to measuring counterparty credit risk for derivative instruments. The Company manages credit risk for its derivative positions on a counterparty-by-counterparty basis (that is, on the basis of its net portfolio exposure with each counterparty), consistent with its risk management strategy for such transactions. The Company manages credit risk by considering indicators of risk such as credit ratings, and by negotiating terms in its ISDA master netting arrangements and, if applicable, any associated Credit Support Annex documentation, with each individual counterparty. Since the effective date of ASC 820, management has monitored and measured credit risk and calculated credit valuation adjustments for its derivative transactions on the basis of its relationships at the counterparty portfolio level. Management receives reports from an independent third-party valuation specialist on a monthly basis providing the credit valuation adjustments at the counterparty portfolio level for purposes of reviewing and managing its credit risk exposures. Since the portfolio exception applies only to the fair value measurement and not to financial statement presentation, the portfolio-level adjustments are then allocated in a reasonable and consistent manner each period to the individual assets or liabilities that make up the group, in accordance with other applicable accounting guidance and the Company's accounting policy elections.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Stock-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant stock-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights (“SARs”), dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date as required by ASC Topic 718. The Company does not currently have any other stock-based compensation issued or outstanding other than restricted stock. Please see Note 8 for additional disclosures regarding the Company's SIP.

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, we evaluate whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed. Please refer to Note 9 for information on the Company's contingencies.

Recent Accounting Pronouncements

There are no recently issued accounting pronouncements which have had or are expected to have a material impact on the Company's consolidated financial statements.

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
ASSETS
Pledged MBS	$ 3,798,331	$ 3,873,584
Common stock, par value	$ 0.01	$ 0.01
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Shares, Issued	54,697,307	54,310,484
Common stock, shares outstanding	54,697,307	54,310,484
Series A Preferred Stock [Member]
ASSETS
Preferred Stock, Par Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	8,000,000	8,000,000
Preferred Stock, Shares Issued	2,300,000	2,300,000
Preferred Stock, Shares Outstanding	2,300,000	2,300,000
Preferred Stock, aggregate liquidation preference	57,500	57,500
Series B Preferred Stock [Member]
ASSETS
Preferred Stock, Par Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	7,000,000	7,000,000
Preferred Stock, Shares Issued	2,250,000	2,250,000
Preferred Stock, Shares Outstanding	2,250,000	2,250,000
Preferred Stock, aggregate liquidation preference	$ 56,250	$ 56,250

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Organization [Text Block]

Organization

Dynex Capital, Inc., ("Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in mortgage-backed securities ("MBS") that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS").

Basis of Presentation [Policy Text Block]

Basis of Presentation

The accompanying consolidated financial statements of Dynex Capital, Inc. and its qualified real estate investment trust (“REIT”) subsidiaries and its taxable REIT subsidiary (together, “Dynex” or the “Company”) have been prepared in accordance with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. The financial information included herein is unaudited; however, in the opinion of management, all significant adjustments, consisting of normal recurring accruals considered necessary for a fair presentation of the consolidated financial statements, have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2014. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC.

Reclassifications [Policy Text Block]

Reclassifications

Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current year’s presentation. The Company's consolidated balance sheet as of December 31, 2013 now presents its "securitized mortgage loans, net" and "other investments, net" together as "mortgage loans held for investment, net". In addition, the Company has combined the presentation of its consolidated statements of income and its consolidated statements of other comprehensive income together as one financial statement which is now titled "consolidated statements of comprehensive income". The Company's "interest income - securitized mortgage loans" and "interest income-other investments" on its consolidated statement of income for the three months ended March 31, 2013 is now presented together as "interest income-mortgage loans held for investment" on its consolidated statement of comprehensive income for the three months ended March 31, 2013. These presentation changes have no effect on reported total assets, total liabilities, results of operations, or cash flow activities.

Consolidation [Policy Text Block]

Consolidation

The consolidated financial statements include the accounts of the Company, its qualified REIT subsidiaries and its taxable REIT subsidiary. The consolidated financial statements represent the Company’s accounts after the elimination of intercompany balances and transactions. The Company consolidates entities in which it owns more than 50% of the voting equity and control does not rest with others and variable interest entities in which it is determined to be the primary beneficiary in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 810-10. The Company follows the equity method of accounting for investments in which it owns greater than a 20% and less than 50% interest in partnerships and corporate joint ventures or when it is able to influence the financial and operating policies of the investee but owns less than 50% of the voting equity. The Company did not have any investments in which it owned less than a 50% interest in the voting equity as of March 31, 2014 or December 31, 2013.

In accordance with ASC Topic 810-10, the Company also consolidates certain trusts through which it has securitized mortgage loans held for investment. Additional information regarding the accounting policy for its securitized mortgage loans is provided below under "Mortgage Loans Held for Investment, Net".

Use of Estimates [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period.  Actual results could differ from those estimates.  The most significant estimates used by management include, but are not limited to, fair value measurements of its investments, allowance for loan losses, other-than-temporary impairments, contingencies, and amortization of premiums and discounts. These items are discussed further below within this note to the consolidated financial statements.

Federal Income Taxes [Policy Text Block]

Federal Income Taxes

The Company believes it has complied with the requirements for qualification as a REIT under the Internal Revenue Code of 1986, as amended (the "Code").  As such, the Company believes that it qualifies as a REIT for federal income tax purposes, and it generally will not be subject to federal income tax on the amount of its income or gain that is distributed as dividends to shareholders.  The Company uses the calendar year for both tax and financial reporting purposes.  There may be differences between taxable income and income computed in accordance with GAAP.

Mortgage Backed Securities [Policy Text Block]

Mortgage-Backed Securities

In accordance with ASC Topic 320, the Company has designated the majority of its investments in MBS as available-for-sale ("AFS"), and the remainder is designated as trading. All of the Company’s MBS are recorded at their fair value on its consolidated balance sheet. Changes in fair value for the Company's AFS securities are reported in other comprehensive income ("OCI") until the security is collected, disposed of, or determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may, from time to time, sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income ("AOCI") into net income as a realized "gain (loss) on sale of investments, net" using the specific identification method. Changes in the fair value of MBS designated as trading are recognized in net income within "fair value adjustments, net". Gains and losses realized upon the sale, impairment, or other disposal of a trading security are also recognized within "fair value adjustments, net".

The Company’s MBS pledged as collateral against repurchase agreements and derivative instruments are included in MBS on the consolidated balance sheets with the fair value of the MBS pledged disclosed parenthetically.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on MBS is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or "IO", securities) and their contractual terms.  Premiums and discounts on Agency MBS as well as any non-Agency MBS rated AA and higher at the time of purchase are amortized into interest income over the expected life of such securities using the effective yield method and adjustments to premium amortization are made for actual prepayment activity as well as changes in projected future cash flows in accordance with ASC Topic 310-20. The Company's projections of future cash flows are based on input and analysis received from external sources and internal models, and includes assumptions about the amount and timing of credit losses, loan prepayment rates, fluctuations in interest rates, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets.

The Company has purchased non-Agency MBS rated less than 'AA' by at least one national rating agency at discounts to their par value, and management does not believe these discounts to be substantial. The Company records the discount accretion into income over the security's expected life, which reflects management's estimate of the security's projected cash flows in accordance with ASC Topic 325-40. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

The accrual of interest on MBS is discontinued when, in the opinion of management, it is probable that all amounts contractually due will not be collected, and in certain instances, as a result of an other-than-temporary impairment analysis (see discussion below). All interest accrued but not collected for investments that are placed on a non-accrual status or are charged-off is reversed against interest income. Interest on these investments is accounted for on the cash-basis or cost-recovery method until the affected investment or investments qualify for return to accrual status. Investments are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured.

Determination of MBS Fair Value.In accordance with ASC Topic 820, the Company determines the fair value for the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company's MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security's coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. The Company's application of ASC Topic 820 guidance is discussed further in Note 7.

Other-than-Temporary Impairment.The Company evaluates all MBS in its investment portfolio for other-than-temporary impairments ("OTTI") by comparing the amortized cost of each security in an unrealized loss position against the present value of expected future cash flows of the security. If there has been a significant adverse change in the cash flow expectations for a security resulting in its amortized cost becoming greater than the present value of its expected future cash flows, an other-than-temporary credit impairment has occurred. If the Company does not intend to sell and is not more likely than not required to sell the security, the credit loss is recognized in earnings and the balance of the unrealized loss is recognized in other comprehensive income (loss). If the Company intends to sell the security or will be more likely than not required to sell the security, the full unrealized loss is recognized in earnings.

In periods after the recognition of an OTTI loss for MBS, the Company accounts for the other-than-temporarily impaired MBS as if the debt security had been purchased on the measurement date of the OTTI at an amortized cost basis equal to the previous amortized cost basis less the OTTI recognized in earnings. For MBS for which OTTIs were recognized in earnings, the difference between the new amortized cost basis and the cash flows expected to be collected shall be accreted into interest income using the effective interest method. The Company continues to estimate the present value of cash flows expected to be collected over the life of the MBS. If upon subsequent evaluation, there is an increase in the cash flows expected to be collected or if actual cash flows are greater than cash flows previously expected, such changes will be accounted for as a prospective adjustment to the accretable yield in accordance with ASC Topic 310-30 even if the MBS would not otherwise be within the scope of that guidance. Please see Note 3 for additional information related to the Company's evaluation for OTTI.

Mortgage Loans Held for Investment, Net [Policy Text Block]

Mortgage Loans Held for Investment, Net

Mortgage loans held for investment consist primarily of securitized mortgage loans reported at amortized cost in accordance with ASC Topic 310-10. Securitized mortgage loans are pledged to support the repayment of securitization financing bonds issued by the Company. The associated securitization financing bonds are treated as debt of the Company and are presented as a portion of "non-recourse collateralized financing" on the consolidated balance sheet. Securitized mortgage loans can only be sold subject to the lien of the respective securitization financing indenture. Less than 2% of the Company's mortgage loans held for investment are unsecuritized; these loans are also reported at amortized cost. In accordance with ASC Topic 310-10, an allowance has been established for currently existing and probable losses on all of the Company's mortgage loans held for investment.

Repurchase Agreements [Policy Text Block]

Repurchase Agreements

Repurchase agreements are treated as financings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments [Policy Text Block]

Derivative Instruments

The Company accounts for its derivative instruments in accordance with ASC Topic 815. ASC Topic 815 requires an entity to recognize all derivatives as either assets or liabilities in the balance sheet and to measure those instruments at fair value.

Effective June 30, 2013, the Company discontinued cash flow hedge accounting for derivative instruments which had previously been accounted for as cash flow hedges under ASC Topic 815. Activity up to and including June 30, 2013 for those agreements previously designated as cash flow hedges was recorded in accordance with cash flow hedge accounting as prescribed by ASC Topic 815, which states that the effective portion of the hedge relationship on an instrument designated as a cash flow hedge is reported in the current period's other comprehensive income while the ineffective portion is immediately reported as a component of the current period’s net income. The balance remaining in AOCI related to the de-designated cash flow hedges is amortized into the Company's net income as a portion of "interest expense" over the remaining life of the interest rate swap agreements. Subsequent to June 30, 2013, changes in the fair value of the Company's derivative instruments, plus periodic settlements, are recorded in the Company's net income as a portion of "loss on derivative instruments, net".

The Company has Eurodollar futures, which are valued based on closing exchange prices. Variation margin is exchanged daily to settle any changes in the value of the Eurodollar futures. Gains and losses associated with purchases and short sales of futures contracts are reported in "loss on derivative instruments, net" on our consolidated statement of comprehensive income.

The Company has elected to use the portfolio exception in ASC 820-10-35-18D with respect to measuring counterparty credit risk for derivative instruments. The Company manages credit risk for its derivative positions on a counterparty-by-counterparty basis (that is, on the basis of its net portfolio exposure with each counterparty), consistent with its risk management strategy for such transactions. The Company manages credit risk by considering indicators of risk such as credit ratings, and by negotiating terms in its ISDA master netting arrangements and, if applicable, any associated Credit Support Annex documentation, with each individual counterparty. Since the effective date of ASC 820, management has monitored and measured credit risk and calculated credit valuation adjustments for its derivative transactions on the basis of its relationships at the counterparty portfolio level. Management receives reports from an independent third-party valuation specialist on a monthly basis providing the credit valuation adjustments at the counterparty portfolio level for purposes of reviewing and managing its credit risk exposures. Since the portfolio exception applies only to the fair value measurement and not to financial statement presentation, the portfolio-level adjustments are then allocated in a reasonable and consistent manner each period to the individual assets or liabilities that make up the group, in accordance with other applicable accounting guidance and the Company's accounting policy elections.

Although MBS have characteristics that meet the definition of a derivative instrument, ASC 815 specifically excludes these instruments from its scope because they are accounted for as debt securities under ASC 320.

Stock-based Compensation [Policy Text Block]

Stock-Based Compensation

Pursuant to the Company’s 2009 Stock and Incentive Plan ("SIP"), the Company may grant stock-based compensation to eligible employees, directors or consultants or advisers to the Company, including stock awards, stock options, stock appreciation rights (“SARs”), dividend equivalent rights, performance shares, and restricted stock units. The Company's restricted stock currently issued and outstanding under this plan may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date as required by ASC Topic 718. The Company does not currently have any other stock-based compensation issued or outstanding other than restricted stock. Please see Note 8 for additional disclosures regarding the Company's SIP.

Contingencies [Policy Text Block]

Contingencies

In the normal course of business, there are various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, we evaluate whether to establish provisions for estimated losses from those matters in accordance with ASC Topic 450, which states that a liability is recognized for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed. Please refer to Note 9 for information on the Company's contingencies.

Recent Accounting Pronouncements [Text Block]

Recent Accounting Pronouncements

There are no recently issued accounting pronouncements which have had or are expected to have a material impact on the Company's consolidated financial statements.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	May 02, 2014
Entity Information [Line Items]
Entity Registrant Name	DYNEX CAPITAL INC
Entity Central Index Key	0000826675
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1
Amendment Flag	true
Amendment Description	Updated to reflect new XBRL data validations implemented since the Original Filing.
Entity Common Stock, Shares Outstanding		54,698,963
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes

XML

Net Income Per Common Share (Tables)

3 Months Ended

Mar. 31, 2014

Earnings Per Share, Basic and Diluted [Abstract]

Schedule of Calculation of Numerator and Denominator in Net Income Per Common Share [Table Text Block]

The following table presents the calculation of the numerator and denominator for both basic and diluted net (loss) income per common share for the periods indicated:

	For the Three Months Ended
	March 31, 2014						March 31, 2013
	Net  Income			Weighted-Average Common Shares			Net  Income			Weighted- Average Common Shares
Net (loss) income	$	(734	)				$	19,603
Preferred stock dividends	(2,294		)				(1,222		)
Net (loss) income to common shareholders	(3,028		)	54,625,601			18,381			54,300,020
Effect of dilutive stock options	—			—			—			754
Diluted net (loss) income to common shareholders	$	(3,028	)	54,625,601			$	18,381		54,300,774
Net (loss) income per common share:
Basic				$	(0.06	)				$	0.34
Diluted (1)				$	(0.06	)				$	0.34

(1) The Company did not have any anti-dilutive securities outstanding during the three months ended March 31, 2014 or March 31, 2013.

XML

Consolidated Statements of Comprehensive Income (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Interest income:
Mortgage-backed securities	$ 26,902	$ 32,039
Mortgage loans held for investment	738	943
Total interest income	27,640	32,982
Interest expense:
Repurchase agreements	7,611	10,218
Non recourse collateralized financing	22	238
Total interest expense	7,633	10,456
Net interest income	20,007	22,526
Provision for loan losses	0	(261)
Loss on derivative instruments, net	(13,422)	(17)
Gain on sale of investments, net	(3,307)	1,391
Fair value adjustments, net	32	(140)
Other income, net	75	(88)
General and administrative expenses:
Compensation and benefits	(2,552)	(2,358)
Other general and administrative	(1,567)	(1,450)
Net (loss) income	(734)	19,603
Preferred Stock Dividends	(2,294)	(1,222)
Net (loss) income to common shareholders	(3,028)	18,381
Change in fair value of available-for-sale securities	23,965	5,897
Reclassification adjustment for (loss) gain on sale of investments, net	(3,307)	1,391
Change in fair value of cash flow hedges	0	437
Reclassification adjustment for cash flow hedges (including de-designated hedges)	(2,288)	(4,103)
Other comprehensive income	29,560	9,046
Comprehensive income to common shareholders	$ 26,532	$ 27,427
Weighted average common shares:
Basic and diluted	54,625,601	54,300,020
Net income per common share:
Net (loss) income per common share - basic and diluted	$ (0.06)	$ 0.34

XML

Offsetting Assets and Liabilities (Notes)

3 Months Ended

Mar. 31, 2014

Offsetting Assets and Liabilities [Abstract]

Schedule of Derivative Instruments Offsetting Assets and Liabilities [Table Text Block]

OFFSETTING ASSETS AND LIABILITIES

The Company's derivatives and repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its assets and liabilities subject to these arrangements on a gross basis. The following tables present information regarding those assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2014 and December 31, 2013:

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Received as Collateral			Cash Received as Collateral
March 31, 2014
Derivative assets	$	12,064	$	—	$	12,064	$	(395	)	$	(7,954	)	$	3,715
December 31, 2013:
Derivative assets	$	18,488	$	—	$	18,488	$	(193	)	$	(12,141	)	$	6,154

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
March 31, 2014
Derivative liabilities	$	11,137	$	—	$	11,137	$	(1,340	)	$	(9,797	)	$	—
Repurchase agreements	3,485,544		—		3,485,544		(3,485,544		)	—			—
	$	3,496,681	$	—	$	3,496,681	$	(3,486,884	)	$	(9,797	)	$	—
December 31, 2013:
Derivative liabilities	$	6,681	$	—	$	6,681	$	(1,299	)	$	(5,382	)	$	—
Repurchase agreements	3,580,754		—		3,580,754		(3,580,754		)	—			—
	$	3,587,435	$	—	$	3,587,435	$	(3,582,053	)	$	(5,382	)	$	—

(1) Amount disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the asset or liability presented in the balance sheet. The fair value of the actual collateral received by or posted to the same counterparty may exceed the amounts presented.

XML

Derivatives

3 Months Ended

Mar. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

DERIVATIVES

     The Company utilizes a variety of derivative instruments to economically hedge a portion of its exposure to market risks, primarily interest rate risk. The principal instruments used to hedge these risks are interest rate swaps and Eurodollar futures. The objective of the Company's risk management strategy is to protect the Company's earnings from rising interest rates and to mitigate declines in book value resulting from fluctuations in the fair value of the Company's assets from changing interest rates. The Company seeks to limit its exposure to changes in interest rates but does not seek to eliminate this risk. Please refer to Note 1 for information related to the Company's accounting policy for its derivative instruments.

The table below summarizes information about the Company’s derivative instruments on its consolidated balance sheet as of the dates indicated:  

			March 31, 2014					December 31, 2013
Type of Derivative Instrument	Accounting Designation	Balance Sheet Location:	Fair Value			Aggregate Notional Amount		Fair Value			Aggregate Notional Amount
Interest rate swaps	Non-hedging	Derivative assets	$	12,064		$	525,000	$	18,488		$	575,000
Interest rate swaps	Non-hedging		$	(1,378	)	$	325,000	$	(1,336	)	$	215,000
Eurodollar futures	Non-hedging		(9,759		)	9,000,000		(5,345		)	9,000,000
		Derivative liabilities	$	(11,137	)	$	9,325,000	$	(6,681	)	$	9,215,000

The following table summarizes activity related to derivative instruments for the periods indicated:

(amounts in thousands)	Interest Rate Swaps			Eurodollar Futures
Notional amount as of December 31, 2013	$	790,000		$	9,000,000
Additions	75,000			—
Settlements, terminations, or expirations	(15,000		)	—
Notional amount as of March 31, 2014(1)	$	850,000		$	9,000,000

(1) The Eurodollar futures notional amount as of March 31, 2014 represents the total notional of the 3-month contracts with expiration dates from 2016 to 2020. The maximum notional outstanding for any future 3-month period does not exceed $1,175,000.

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of March 31, 2014:

Remaining Maturity	Notional Amount		Weighted-Average Fixed Rate Swapped
37-48 months	185,000		0.92	%
49-60 months	350,000		1.62	%
61-72 months	35,000		1.24	%
73-84 months	100,000		2.08	%
85-108 months	—		—	%
109-127 months	180,000		2.13	%
	$	850,000	1.61	%

The tables below summarize the effect of the Company's interest rate derivatives reported in "loss on derivative instruments, net" within the Company's net income for the periods indicated:

	Three Months Ended
	March 31,
Type of Derivative Instrument	2014			2013
Interest rate swaps	$	(9,008	)	$	(17	)
Eurodollar futures	(4,414		)	—
Loss on derivative instruments, net	$	(13,422	)	$	(17	)

Effective June 30, 2013, the Company de-designated certain interest rate swap agreements as cash flow hedges under ASC Topic 815. The net unrealized loss in AOCI of $7,077 remaining on the Company's consolidated balance sheet as of March 31, 2014 is related to these interest rate swap agreements. The amount remaining in AOCI will be recognized in the Company's net income as a portion of "interest expense" over the remaining contractual life of the agreements. All forecasted transactions associated with interest rate swap agreements previously designated as cash flow hedges are expected to occur. No amounts have been reclassified to net income in any period in connection with forecasted transactions that are no longer considered probable of occurring. The Company estimates the portion of existing net unrealized loss on discontinued cash flow hedges expected to be reclassified to net income within the next 12 months is $5,525. The Company reclassified $2,288 from AOCI to net income for the three months ended March 31, 2014 related to amortization of the net unrealized loss remaining in AOCI at the time the Company discontinued its cash flow hedge accounting. For the three months ended March 31, 2013, the Company reclassified $4,103 from AOCI to net income related to recognition of interest expense from cash flow hedging transactions.

Many of the Company's interest rate swaps were entered into under bilateral agreements which contain various covenants related to the Company’s credit risk. Specifically, if the Company defaults on any of its indebtedness, including those circumstances whereby repayment of the indebtedness has not yet been accelerated by the lender, or is declared in default of any of its covenants with any counterparty, then the Company could also be declared in default under the bilateral agreement. Additionally, these agreements allow those counterparties to require settlement of its outstanding derivative transactions if the Company fails to earn GAAP net income excluding derivative gains and losses greater than one dollar as measured on a rolling two quarter basis. These interest rate agreements also contain provisions whereby, if the Company fails to maintain a minimum net amount of shareholders’ equity, then the Company may be declared in default on its derivative obligations. The Company was in compliance with all covenants under bilateral agreements on March 31, 2014.

XML

Offsetting Assets and Liabilities Offsetting Liabilities (Tables)

3 Months Ended

Mar. 31, 2014

Offsetting Liabilities [Line Items]

Offsetting Liabilities [Table Text Block]

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet						Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
March 31, 2014
Derivative liabilities	$	11,137	$	—	$	11,137	$	(1,340	)	$	(9,797	)	$	—
Repurchase agreements	3,485,544		—		3,485,544		(3,485,544		)	—			—
	$	3,496,681	$	—	$	3,496,681	$	(3,486,884	)	$	(9,797	)	$	—
December 31, 2013:
Derivative liabilities	$	6,681	$	—	$	6,681	$	(1,299	)	$	(5,382	)	$	—
Repurchase agreements	3,580,754		—		3,580,754		(3,580,754		)	—			—
	$	3,587,435	$	—	$	3,587,435	$	(3,582,053	)	$	(5,382	)	$	—

XML

Mortgage Backed Securities Mortgage backed securities (Tables)

3 Months Ended

Mar. 31, 2014

Investments, Debt and Equity Securities [Abstract]

Available-for-sale Securities [Table Text Block]

The following table presents the components and weighted average coupon ("WAC") for the portion of the Company’s MBS designated as AFS as of March 31, 2014 and December 31, 2013:

	March 31, 2014
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,438,133	$	139,899		$	2,578,032	$	6,708	$	(45,438	)	$	2,539,302	3.20	%
CMBS	286,931		19,838			306,769		11,384		(509		)	317,644		5.23	%
CMBS IO (1)	—		461,523			461,523		11,581		(1,859		)	471,245		0.94	%
Total Agency AFS:	2,725,064		621,260			3,346,324		29,673		(47,806		)	3,328,191
Non-Agency:
RMBS	15,454		(7		)	15,447		209		(86		)	15,570		4.42	%
CMBS	375,209		(17,819		)	357,390		19,448		(842		)	375,996		5.05	%
CMBS IO (1)	—		209,301			209,301		3,374		(1,148		)	211,527		0.80	%
Total non-Agency AFS:	390,663		191,475			582,138		23,031		(2,076		)	603,093
Total AFS securities	$	3,115,727	$	812,735		$	3,928,462	$	52,704	$	(49,882	)	$	3,931,284

(1) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $10,582,484 and $5,053,884, respectively, as of March 31, 2014.

	December 31, 2013
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC
Agency:
RMBS	$	2,591,568	$	154,220		$	2,745,788	$	6,104	$	(59,742	)	$	2,692,150	3.22	%
CMBS	273,830		19,061			292,891		10,793		(900		)	302,784		5.07	%
CMBS IO (1)	—		453,766			453,766		9,895		(3,334		)	460,327		0.83	%
Total Agency AFS:	2,865,398		627,047			3,492,445		26,792		(63,976		)	3,455,261
Non-Agency:
RMBS	13,845		(338		)	13,507		338		(80		)	13,765		4.61	%
CMBS	375,703		(18,277		)	357,426		15,366		(3,511		)	369,281		5.10	%
CMBS IO (1)	—		150,518			150,518		2,618		(1,999		)	151,137		0.66	%
Total non-Agency AFS:	389,548		131,903			521,451		18,322		(5,590		)	534,183
Total AFS securities	$	3,254,946	$	758,950		$	4,013,896	$	45,114	$	(69,566	)	$	3,989,444

(1) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $10,160,502 and $4,274,957, respectively, as of December 31, 2013.

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block]

The following table presents certain information for those Agency MBS in an unrealized loss position as of March 31, 2014 and December 31, 2013:

	March 31, 2014						December 31, 2013
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	1,563,078	$	(29,207	)	120	$	1,912,937	$	(43,543	)	150
Non-Agency MBS	126,578		(1,990		)	23	162,558		(5,435		)	39
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	767,744	$	(18,600	)	80	$	670,402	$	(20,433	)	67
Non-Agency MBS	1,676		(86		)	5	6,310		(155		)	6

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

The Company and its subsidiaries are parties to various legal proceedings. Although the ultimate outcome of those legal proceedings cannot be ascertained at this time, and the results of legal proceedings cannot be predicted with certainty, the Company believes, based on current knowledge, that the resolution of any of these proceedings will not have a material effect on the Company’s consolidated financial condition or liquidity. However, the resolution of any of those proceedings could have a material impact on consolidated results of operations or cash flows in a given future reporting period as the proceedings are resolved. Please refer to Note 1 for information on the Company's accounting policy with respect to accrual for loss contingencies. There have been no material changes during the three months ended March 31, 2014 for the legal proceedings discussed in our Annual Report on Form 10-K for the year ended December 31, 2013.

XML

Fair Value of Financial Instruments (Notes)

3 Months Ended

Mar. 31, 2014

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity's own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. The fair value measurement of the Company's Eurodollar futures contracts are included in this category.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  The Company’s assets and liabilities measured at fair value that are generally included in this category are Agency MBS, certain non-Agency MBS, and interest rate swaps.

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date.  Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  The Company’s assets and liabilities measured at fair value that are generally included in this category are certain non-Agency MBS.

The following table presents the fair value of the Company’s assets and liabilities presented on its consolidated balance sheets, segregated by the hierarchy level of the fair value estimate, that are measured at fair value on a recurring basis as of the dates indicated:

	March 31, 2014
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	3,959,852	$	—	$	3,893,465	$	66,387
Derivative assets	12,064		—		12,064		—
Total assets carried at fair value	$	3,971,916	$	—	$	3,905,529	$	66,387
Liabilities:
Derivative liabilities	$	11,137	$	9,759	$	1,378	$	—
Total liabilities carried at fair value	$	11,137	$	9,759	$	1,378	$	—

	December 31, 2013
	Fair Value		Level 1 - Unadjusted Quoted Prices in Active Markets		Level 2 - Observable Inputs		Level 3 - Unobservable Inputs
Assets:
Mortgage-backed securities	$	4,018,161	$	—	$	3,944,681	$	73,480
Derivative assets	18,488		—		18,488		—
Total assets carried at fair value	$	4,036,649	$	—	$	3,963,169	$	73,480
Liabilities:
Derivative liabilities	$	6,681	$	5,345	$	1,336	$	—
Total liabilities carried at fair value	$	6,681	$	5,345	$	1,336	$	—

The Company did not have assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2014 or December 31, 2013.

The Company’s valuation of its interest rate swaps is determined using the income approach. Derivative assets and liabilities include interest rate swaps and Eurodollar futures. The primary input into the valuation of interest rate swaps is the forward interest rate swap curve, which is considered an observable input and thus their fair values are considered Level 2 measurements. The Company's valuation of its Eurodollar futures is based on the closing exchange prices. Accordingly, these financial futures are classified as Level 1.

The Company’s Agency MBS, as well a majority of its non-Agency MBS, are substantially similar to securities that either are currently actively traded or have been recently traded in their respective market. Their fair values are derived from an average of multiple dealer quotes and thus are considered Level 2 fair value measurements. The Company’s remaining non-Agency MBS are comprised of securities for which there are not substantially similar securities that trade frequently, and their fair values are therefore considered Level 3 measurements. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using assumptions that are confirmed to the extent possible by third party dealers or other pricing indicators. Significant inputs into those pricing models are Level 3 in nature due to the lack of readily available market quotes. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation would result in a significantly different fair value measurement. Generally Level 3 assets are most sensitive to the default rate and severity assumptions.

The table below presents information about the significant unobservable inputs used in the fair value measurement for the Company's Level 3 non-Agency CMBS and RMBS as of March 31, 2014:

	Quantitative Information about Level 3 Fair Value Measurements (1)
	Prepayment Speed	Default Rate		Severity		Discount Rate
Non-Agency CMBS	20 CPY	2.5	%	35.0	%	8.8	%
Non-Agency RMBS	10 CPR	1.0	%	20.0	%	6.8	%

(1) Data presented are weighted averages.

The following table presents the activity of the instruments fair valued at Level 3 during the three months ended March 31, 2014:

	Three Months
	March 31, 2014
	Level 3 Fair Values
	Non-Agency CMBS			Non-Agency RMBS			Total assets
Balance as of December 31, 2013	$	70,733		$	2,747		$	73,480
Change in fair value included in OCI	27			(126		)	(99		)
Principal payments	(6,993		)	(395		)	(7,388		)
Accretion	65			329			394
Balance as of March 31, 2014	$	63,832		$	2,555		$	66,387

The following table presents a summary of the recorded basis and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2014				December 31, 2013
	Recorded Basis		Fair Value		Recorded Basis		Fair Value
Assets:
Mortgage-backed securities	$	3,959,852	$	3,959,852	$	4,018,161	$	4,018,161
Mortgage loans held for investment, net (1)	53,804		45,188		55,423		46,383
Derivative assets	12,064		12,064		18,488		18,488
Liabilities:
Repurchase agreements (2)	$	3,485,544	$	3,485,683	$	3,580,754	$	3,580,997
Non-recourse collateralized financing (1)	12,394		11,915		12,914		12,414
Derivative liabilities	11,137		11,137		6,681		6,681

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate fair value of the Company's Level 3 non-Agency MBS.

(2) The difference between the recorded basis of repurchase agreements and their fair value is the deferred cost of the 2-year repurchase facility.

XML

Shareholders' Equity

3 Months Ended

Mar. 31, 2014

Equity [Abstract]

Shareholders' Equity

SHAREHOLDERS' EQUITY

Preferred Stock

The Company has 2,300,000 shares of its 8.50% Series A Cumulative Redeemable Preferred Stock and 2,250,000 shares of its 7.625% Series B Cumulative Redeemable Preferred Stock issued and outstanding as of March 31, 2014 (collectively, the "Preferred Stock"). The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. Except under certain limited circumstances intended to preserve the Company's REIT status, upon the occurrence of a change in control as defined in Article IIIA, Section 7(d) of the Company’s Articles of Incorporation, or to avoid the direct or indirect imposition of a penalty tax in respect of, or to protect the tax status of, any of the Company’s real estate mortgage investment conduits (“REMIC”) interests or a REMIC in which the Company may acquire an interest (as permitted by the Company’s Articles of Incorporation), the Company may not redeem the Series A Preferred Stock prior to July 31, 2017 or the Series B Preferred Stock prior to April 30, 2018. On or after these dates, at any time and from time to time, the Preferred Stock may be redeemed in whole, or in part, at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company's consolidated balance sheet.

Common Stock

The following table presents a summary of the changes in the number of common shares outstanding for the periods presented:

	Three Months Ended
	March 31,
	2014		2013
Balance as of beginning of period	54,310,484		54,268,915
Common stock issued under DRIP	3,938		298,304
Common stock issued under ATM program	—		180,986
Common stock issued or redeemed under stock and incentive plans	442,035		139,600
Common stock forfeited for tax withholding on share-based compensation	(59,150	)	(52,385	)
Balance as of end of period	54,697,307		54,835,420

The Company had approximately 7,416,520 shares of common stock that remain available to offer and sell through its sales agent, JMP Securities LLC, under its "at the market", or "ATM" program, as of March 31, 2014.

The Company's Dividend Reinvestment and Share Purchase Plan ("DRIP") allows registered shareholders to automatically reinvest some or all of their quarterly common stock dividends in shares of the Company’s common stock and provides an opportunity for investors to purchase shares of the Company’s common stock, potentially at a discount to the prevailing market price. Of the 3,000,000 shares reserved for issuance under the Company's DRIP, there were 2,462,960 shares remaining for issuance as of March 31, 2014. The Company declared a first quarter common stock dividend of $0.25 per share payable on April 30, 2014 to shareholders of record as of April 4, 2014. There was no discount for shares purchased through the DRIP during the first quarter of 2014.

Of the $50,000 authorized by the Company's Board of Directors for the repurchase of its common stock through December 31, 2014, approximately $42,145 remains available for repurchase at the Company's option as of March 31, 2014.

2009 Stock and Incentive Plan. Of the 2,500,000 shares of common stock authorized for issuance under its 2009 Stock and Incentive Plan, the Company had 1,108,083 available for issuance as of March 31, 2014. Total stock-based compensation expense recognized by the Company for the three months ended March 31, 2014 was $672 compared to $489 for the three months ended March 31, 2013.

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2014		2013
Restricted stock outstanding as of beginning of period	520,969		448,283
Restricted stock granted	428,363		139,600
Restricted stock vested	(188,620	)	(153,720	)
Restricted stock outstanding as of end of period	760,712		434,163

 The restricted stock granted during the three months ended March 31, 2014 and March 31, 2013 had combined fair values of $3,453 and $1,491, respectively, at their grant dates. As of March 31, 2014, the balance of the Company’s outstanding restricted stock remaining to be amortized into compensation expense is $6,092 of which $1,902 is expected to be amortized in the remaining nine months of 2014, $2,161 in 2015, $1,452 in 2016, $541 in 2017, and $36 in 2018. The Company did not have any other type of stock-based compensation issued or outstanding as of March 31, 2014 or December 31, 2013 other than its restricted stock.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2014

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

XML

Offsetting Assets and Liabilities Offsetting Assets (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 12,064	$ 18,488
Derivative Asset, Fair Value, Gross Liability	0	0
Derivative Asset, Fair Value, Amount Not Offset Against Collateral	12,064	18,488
Derivative, Collateral, Obligation to Return Securities	(395)	(193)
Derivative, Collateral, Obligation to Return Cash	(7,954)	(12,141)
Derivative Asset, Fair Value, Amount Offset Against Collateral	$ 3,715	$ 6,154

XML

Derivatives (Tables)

3 Months Ended

Mar. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The table below summarizes information about the Company’s derivative instruments on its consolidated balance sheet as of the dates indicated:  

			March 31, 2014					December 31, 2013
Type of Derivative Instrument	Accounting Designation	Balance Sheet Location:	Fair Value			Aggregate Notional Amount		Fair Value			Aggregate Notional Amount
Interest rate swaps	Non-hedging	Derivative assets	$	12,064		$	525,000	$	18,488		$	575,000
Interest rate swaps	Non-hedging		$	(1,378	)	$	325,000	$	(1,336	)	$	215,000
Eurodollar futures	Non-hedging		(9,759		)	9,000,000		(5,345		)	9,000,000
		Derivative liabilities	$	(11,137	)	$	9,325,000	$	(6,681	)	$	9,215,000

Description of Derivative Activity Volume

The following table summarizes activity related to derivative instruments for the periods indicated:(amounts in thousands)Interest Rate Swaps Eurodollar FuturesNotional amount as of December 31, 2013$790,000 $9,000,000Additions75,000 —Settlements, terminations, or expirations(15,000) —Notional amount as of March 31, 2014(1)$850,000 $9,000,000(1)The Eurodollar futures notional amount as of March 31, 2014 represents the total notional of the 3-month contracts with expiration dates from 2016 to 2020. The maximum notional outstanding for any future 3-month period does not exceed $1,175,000.

Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]

The following table summarizes the contractual maturities remaining for the Company’s outstanding interest rate swap agreements as of March 31, 2014:

Remaining Maturity	Notional Amount		Weighted-Average Fixed Rate Swapped
37-48 months	185,000		0.92	%
49-60 months	350,000		1.62	%
61-72 months	35,000		1.24	%
73-84 months	100,000		2.08	%
85-108 months	—		—	%
109-127 months	180,000		2.13	%
	$	850,000	1.61	%

Schedule of Derivative Instruments Included in Trading Activities [Table Text Block]

The tables below summarize the effect of the Company's interest rate derivatives reported in "loss on derivative instruments, net" within the Company's net income for the periods indicated:

	Three Months Ended
	March 31,
Type of Derivative Instrument	2014			2013
Interest rate swaps	$	(9,008	)	$	(17	)
Eurodollar futures	(4,414		)	—
Loss on derivative instruments, net	$	(13,422	)	$	(17	)

XML

Net Income Per Common Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net (loss) income	$ (734)	$ 19,603
Preferred Stock Dividends	(2,294)	(1,222)
Net (loss) income to common shareholders	(3,028)	18,381
Effect of dilutive stock options, income	0
Diluted net (loss) income	$ (3,028)	$ 18,381
Weighted Average Common Shares	54,625,601	54,300,020
Effect of dilutive stock options, number of shares	0	754
Diluted, Weighted Average Number Common Shares	54,625,601	54,300,774
Basic	$ (0.06)	$ 0.34
Diluted Net Income Per Common Share	$ (0.06)	$ 0.34

XML

Shareholders' Equity Share-based Compensation (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based incentive plan, number of shares authorized for issuance	2,500,000
Share-based incentive plan, number of shares remaining for issuance	1,108,083
Total share-based compensation expense	$ 672	$ 489
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Granting and vesting of restricted stock	672	456
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Restricted stock outstanding at beginning of the period	520,969	448,283
Restricted stock granted during the period	428,363	139,600
Restricted stock vested during the period	(188,620)	(153,720)
Restricted stock outstanding at end of the period	760,712	434,163
Granting and vesting of restricted stock	3,453	1,491
Nonvested restricted stock, fair value remaining to be amortized	6,092
Restricted Stock [Member] | Up to one year [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	1,902
Restricted Stock [Member] | Two to three years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	2,161
Restricted Stock [Member] | Three to four years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	1,452
Restricted Stock [Member] | Four to five years [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	541
Restricted Stock [Member] | Five years or more [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options
Nonvested restricted stock, fair value remaining to be amortized	$ 36

XML

Consolidated Statements of Shareholders' Equity Statement (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Preferred Stock Dividends, Income Statement Impact	$ 2,294	$ 1,222
Total shareholders' equity	599,015	633,298	585,876	616,710
Stock issuance	144	5,183
Granting and vesting of restricted stock	672	456
Amortization of stock issuance costs	(30)	(30)
Adjustments for tax withholding on share-based compensation	(505)	(546)
Net (loss) income	(734)	19,603
Dividends on preferred stock	(2,294)	(1,222)
Dividends on common stock	(13,674)	(15,902)
Other comprehensive income	29,560	9,046
Preferred Stock Including Additional Paid in Capital [Member]
Total shareholders' equity	109,658	55,407	109,658	55,407
Stock issuance	0
Common Stock [Member]
Total shareholders' equity	547	548	543	543
Stock issuance	1	5
Granting and vesting of restricted stock	4	1
Adjustments for tax withholding on share-based compensation	(1)	(1)
Additional Paid-in Capital [Member]
Total shareholders' equity	761,827	764,272	761,550	759,214
Stock issuance	143	5,178
Granting and vesting of restricted stock	668	455
Amortization of stock issuance costs	(30)	(30)
Adjustments for tax withholding on share-based compensation	(504)	(545)
Accumulated Other Comprehensive (Loss) Income [Member]
Total shareholders' equity	(4,256)	61,557	(33,816)	52,511
Accumulated Deficit [Member]
Total shareholders' equity	(268,761)	(248,486)	(252,059)	(250,965)
Dividends on common stock	$ (13,674)	$ (15,902)

XML

Repurchase Agreements

3 Months Ended

Mar. 31, 2014

REPURCHASE AGREEMENTS [Abstract]

Repurchase Agreements

REPURCHASE AGREEMENTS

The following tables present the components of the Company’s repurchase agreements as of March 31, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	March 31, 2014
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,350,781		0.39	%	2,421,202
Agency CMBS	265,475			0.37	%	330,182
Agency CMBS IOs	382,327			1.14	%	471,173
Non-Agency RMBS	11,905			1.77	%	14,691
Non-Agency CMBS	309,398			1.22	%	371,273
Non-Agency CMBS IO	149,105			1.23	%	187,227
Securitization financing bonds	16,692			1.52	%	18,607
Deferred costs	(139		)	n/a		n/a
	$	3,485,544		0.59	%	$	3,814,355

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

The combined weighted average original term to maturity for the Company’s repurchase agreements decreased to 93 days as of March 31, 2014 from 114 days as of December 31, 2013. The following table provides a summary of the original maturities as of March 31, 2014 and December 31, 2013:

Original Maturity	March 31, 2014		December 31, 2013
30 days or less	$	369,542	$	206,112
31 to 60 days	715,516		492,145
61 to 90 days	987,579		665,020
91 to 120 days	545,628		783,371
121 to 190 days	867,418		1,434,349
	$	3,485,683	$	3,580,997

As of March 31, 2014, the Company had approximately $97,517 of its shareholders' equity at risk (defined as the excess of collateral pledged over the borrowing outstanding) with Wells Fargo Bank National Association together with its affiliate Wells Fargo Securities, LLC. The borrowings outstanding with that counterparty and its affiliates as of March 31, 2014 were $348,399 with a weighted average borrowing rate of 1.27%. Of the amount outstanding with this counterparty and its affiliate, $165,693 is under a two-year repurchase facility with Wells Fargo Bank National Association. The facility provides an aggregate maximum borrowing capacity of $250,000 and matures on August 6, 2015, subject to early termination provisions contained in the master repurchase agreement. The facility is collateralized primarily by CMBS IO, and its weighted average borrowing rate as of March 31, 2014 was 1.42%. Shareholders' equity at risk did not exceed 10% for any of the Company's other counterparties.

As of March 31, 2014, the Company had repurchase agreement amounts outstanding with 21 of its 31 available counterparties. The Company's counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company's REIT status.  In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in compliance with all covenants as of March 31, 2014.

XML

Mortgage Backed Securities Mortgage backed securities designated as AFS (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended			3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014 Agency MBS [Member]	Dec. 31, 2013 Agency MBS [Member]	Mar. 31, 2014 Agency MBS [Member] Residential Mortgage Backed Securities [Member]	Dec. 31, 2013 Agency MBS [Member] Residential Mortgage Backed Securities [Member]	Mar. 31, 2014 Agency MBS [Member] Commercial Mortgage Backed Securities [Member]	Dec. 31, 2013 Agency MBS [Member] Commercial Mortgage Backed Securities [Member]	Mar. 31, 2014 Agency MBS [Member] CMBS IO [Member]	Dec. 31, 2013 Agency MBS [Member] CMBS IO [Member]	Mar. 31, 2014 Non-Agency MBS [Member]	Dec. 31, 2013 Non-Agency MBS [Member]	Mar. 31, 2014 Non-Agency MBS [Member] Residential Mortgage Backed Securities [Member]	Dec. 31, 2013 Non-Agency MBS [Member] Residential Mortgage Backed Securities [Member]	Mar. 31, 2014 Non-Agency MBS [Member] Commercial Mortgage Backed Securities [Member]	Dec. 31, 2013 Non-Agency MBS [Member] Commercial Mortgage Backed Securities [Member]	Mar. 31, 2014 Non-Agency MBS [Member] CMBS IO [Member]	Dec. 31, 2013 Non-Agency MBS [Member] CMBS IO [Member]	Mar. 31, 2014 Agency MBS [Member]	Mar. 31, 2013 Agency MBS [Member]	Dec. 31, 2013 Agency MBS [Member]	Mar. 31, 2014 Non-Agency MBS [Member]	Mar. 31, 2013 Non-Agency MBS [Member]	Dec. 31, 2013 Non-Agency MBS [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale MBS, Par Balance	$ 3,115,727	$ 3,254,946	$ 2,725,064	$ 2,865,398	$ 2,438,133	$ 2,591,568	$ 286,931	$ 273,830	$ 0	$ 0	$ 390,663	$ 389,548	$ 15,454	$ 13,845	$ 375,209	$ 375,703	$ 0	$ 0
Investments, Unamortized Premium (Discount)	812,735	758,950	621,260	627,047	139,899	154,220	19,838	19,061	461,523	453,766	191,475	131,903	(7)	(338)	(17,819)	(18,277)	209,301	150,518
Notional balance for interest only securities									10,582,484	10,160,502							5,053,884	4,274,957
Available-for-sale MBS, Amortized Cost	3,928,462	4,013,896	3,346,324	3,492,445	2,578,032	2,745,788	306,769	292,891	461,523	453,766	582,138	521,451	15,447	13,507	357,390	357,426	209,301	150,518
Available-for-sale MBS, Gross Unrealized Gain	52,704	45,114	29,673	26,792	6,708	6,104	11,384	10,793	11,581	9,895	23,031	18,322	209	338	19,448	15,366	3,374	2,618
Available-for-sale MBS, Gross Unrealized Loss	49,882	69,566	47,806	63,976	45,438	59,742	509	900	1,859	3,334	2,076	5,590	(86)	80	842	3,511	(1,148)	1,999
Available-for-sale MBS, Fair Value	3,931,284	3,989,444	3,328,191	3,455,261	2,539,302	2,692,150	317,644	302,784	471,245	460,327	603,093	534,183	15,570	13,765	375,996	369,281	211,527	151,137
Available-for-sale MBS, Weighted Average Coupon					3.20%	3.22%	5.23%	5.07%	0.94%	0.83%			4.42%	4.61%	5.05%	5.10%	0.80%	0.66%
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value																			1,563,078		1,912,937	126,578		162,558
Available-for-sale MBS, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses																			(29,207)	(43,543)		(1,990)	(5,435)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Less than One Year																			120		150	23		39
Available-for-sale MBS, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value																			767,744		670,402	1,676		6,310
Available-for-sale MBS, Continuous Unrealized Loss Position, 12 Months or Longer, Gross Unrealized Losses																			$ (18,600)	$ (20,433)		$ (86)	$ (155)
Available-for-sale MBS, Number of Securities in Continuous Unrealized Loss Position for Greater than or Equal to One Year																			80		67	5		6

XML

Fair Value of Financial Instruments Level 3 (Details) (Fair Value, Measurements, Recurring [Member], Fair Value, Inputs, Level 3 [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	$ 73,480
Unrealized (loss) gain included in OCI	(99)
Principal payments	(7,388)
Amortization	394
Balance at the end of the period	66,387
Non-Agency CMBS [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	70,733
Unrealized (loss) gain included in OCI	27
Principal payments	(6,993)
Amortization	65
Balance at the end of the period	63,832
Non-Agency RMBS [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	2,747
Unrealized (loss) gain included in OCI	(126)
Principal payments	(395)
Amortization	329
Balance at the end of the period	$ 2,555

XML

Repurchase Agreements Repurchase Agreements (Tables)

3 Months Ended

Mar. 31, 2014

Transfers and Servicing [Abstract]

Schedule of Assets and Associated Liabilities Accounted for as Secured Borrowings [Table Text Block]

The following tables present the components of the Company’s repurchase agreements as of March 31, 2014 and December 31, 2013 by the fair value and type of securities pledged as collateral:

	March 31, 2014
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,350,781		0.39	%	2,421,202
Agency CMBS	265,475			0.37	%	330,182
Agency CMBS IOs	382,327			1.14	%	471,173
Non-Agency RMBS	11,905			1.77	%	14,691
Non-Agency CMBS	309,398			1.22	%	371,273
Non-Agency CMBS IO	149,105			1.23	%	187,227
Securitization financing bonds	16,692			1.52	%	18,607
Deferred costs	(139		)	n/a		n/a
	$	3,485,544		0.59	%	$	3,814,355

	December 31, 2013
Collateral Type	Balance			Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,522,503		0.42	%	2,598,158
Agency CMBS	246,849			0.39	%	306,318
Agency CMBS IOs	369,948			1.16	%	449,072
Non-Agency RMBS	10,569			1.80	%	12,746
Non-Agency CMBS	303,674			1.27	%	367,859
Non-Agency CMBS IOs	106,803			1.27	%	136,227
Securitization financing bonds	20,651			1.59	%	19,686
Deferred costs	(243		)	n/a		n/a
	$	3,580,754		0.61	%	$	3,890,066

Repurchase Agreements, Original Maturity Schedule [Table Text Block]

The following table provides a summary of the original maturities as of March 31, 2014 and December 31, 2013:

Original Maturity	March 31, 2014		December 31, 2013
30 days or less	$	369,542	$	206,112
31 to 60 days	715,516		492,145
61 to 90 days	987,579		665,020
91 to 120 days	545,628		783,371
121 to 190 days	867,418		1,434,349
	$	3,485,683	$	3,580,997